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Choline and vitamin B12 are essential nutrients for growth and performances of production 
animals. However, both nutrients are extensively degraded during digestion in the rumen. This 
thesis comprised three experiments. First, four cows equipped with a rumen cannula and 
catheters in the portal vein and a mesenteric artery received a post-ruminal bolus of: 1) 
cyanocobalamin (CN-CBL) alone (0.1 g) [gram], 2) CN-CBL (0.1 g) + casein (10 g) or 3) CN-
CBL (0.1 g) + whey proteins (10 g). After the bolus, blood samples were taken until 24 h [hour] 
post-bolus. The intestinal absorption of CN-CBL was greater when the vitamin was given in 
solution with casein (4 μg [micro-gram]/h) compared with CN-CBL given alone or with whey 
protein (-25 μg/h and -19 μg/h, respectively). Second, a LC-MS/MS methodology was 
established for differentiation of choline metabolites in blood and milk, from different 
physiological states of the lactating cow. Total choline concentration in plasma, which was 
almost entirely phosphatidylcholine, increased 10-fold from early to late lactation (1,305 to 
13,535 μmol/L [micro-mol per liter]). In milk, phosphocholine was the main metabolite in early 
lactation (492 μmol/L), but decreased exponentially through lactation to 43 μmol/L in late 
lactation. In contrast, phosphatidylcholine in milk was the main metabolite in mid and late 
lactation (188 μmol/L and 659 μmol/L, respectively). Third, the choline metabolites were 
measured in milk and blood after post-ruminal infusion (ABO) of choline chloride or dietary 
supplemented with rumen protected choline (RPC) in a low dose 12.5 g (L) and high dose 25 g 
(H) choline/d, respectively. Although lipid soluble metabolites or total choline in plasma were 
not affected by treatments, total choline was transfer into milk at a low level, 2% RPC-H and 5% 






addition of casein may improve CN-CBL absorption in dairy cows; second, milk from dairy 
cows at early lactation is higher in phosphocholine and thus might be used for infant formula to 
better match breast milk; third, prediction of choline supply may be possible based on betaine 
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Choline and vitamin B12 have several essential metabolic functions in mammalian animals, 
including the methylneogenesis or one-carbon metabolism, by which methyl groups are 
transferred to homocysteine to form methionine. Methionine is the precursor for s-
adenosylmethionine, the main intermediate in the methylation of nucleic acids, lipids and 
proteins.  
In dairy cows, the majority of choline and vitamin B12 in feed ingredients is degraded in the 
rumen (NRC, 2001). To prevent ruminal degradation, rumen protected (RP) products were 
developed that were successful in reducing liver triglycerides (TAG), consistent with the 
biological action of choline. However, the amount of choline absorbed in the small intestine (i.e., 
choline bioavailability) and its metabolism remains unknown. The combination with folic acid 
and vitamin B12 delivered by intramuscular injection increased milk components yield (e.g., fat 
and total solid yield), owing to improved metabolic efficiency. However, such performance 
improvements are too costly and not feasible under commercial conditions. The following 
dissertation will be divided in four chapters. The first chapter will focus on reviewing the 
literature on structure and functions of choline and vitamin B12 as well as describing the net-flux 
of a nutrient through the gastrointestinal tract. The second chapter will evaluate the casein and 
whey proteins as a delivery system to increase the intestinal absorption in dairy cows. The third 
chapter will focus on characterization of choline metabolites in blood and milk during lactation 
in dairy cows. The fourth chapter will evaluate the effect of post-ruminal infusion and rumen 










Structure and synthesis of isomeric forms 
Vitamin B12, also called cobalamin (Cbl), is a water-soluble vitamin with a key role in the 
normal functioning of the brain and nervous system. It is the largest (MW=1355.4 Da) and most 
chemically complex of all the vitamins (Kozyraki and Cases, 2013). It consists of a central cobalt 
atom surrounded by six coordination sites. Four coordination sites contain corrin rings, one 
contains a dimethylbenzimidazole group, and one coordination site, the center of reactivity, is 
variable giving the different isomeric forms of vitamin B12: a cyano group (-CN), a hydroxyl 
group (-OH), a methyl group (-CH3), or a 5'-deoxyadenosyl group (Watanabe, 2007). All the 
vitamin B12 isomers could form deeply red-colored crystals, due to the exposure of the cobalt-
corrin complex to water (Herbert, 1988).  
The synthetic isomers of cobalamin are cyanocobalamin and hydroxycobalamin, produced by 
bacterial synthesis, and converted to the biologically active isomers (i.e. methylcobalamin and 
adenosylcobalamin) after absorption. The industrial synthesis of cobalamin is a multi-step bio-
synthetic fermentation process that requires selected microbial strains able produce high yields of 
vitamin B12 (Martens et al., 2002). Cyanocobalamin (CN-CBL) is commercially prepared adding 
a cyano group to stabilize cobalamin otherwise destroyed under light exposure. Since the 
cyanocobalamin form of vitamin B12 is easy to crystallize and is not sensitive to air-oxidation, it 
is typically used as a form of vitamin B12 for food additives and multivitamin supplements 
(Herbert, 1988). Hydroxycobalamin is another form of vitamin B12 commonly found in 
pharmaceutical products, which is produced by bacteria and typically supplied as a liquid 






Distribution in food 
The synthesis of vitamin B12 is limited exclusively to bacteria. Thus, this vitamin is present only 
in foods that were bacterially fermented and those derived from the tissues of animals that 
obtained vitamin B12 from their rumen or dietary supplement (Combs Jr, 1998). Animal tissues 
that accumulate vitamin B12 (e.g., liver and kidney) are excellent food sources of vitamin B12 
(Table 1.1). The richest food sources of vitamin B12 are dairy products, meats, eggs, fish, and 
shellfish. The main vitamin B12 isomeric forms in foods are methylcobalamin, 
deoxyadenosylcobalamin, and hydroxycobalamin. The main natural sources of vitamin B12 for 
animal feedstuffs are animal by-products such as meat and bone meal, fish meal, and cheese 
whey (Combs Jr, 1998). 
 
Digestion, Absorption and Metabolism 
Inhumans, vitamin B12 absorption is mediated by protein binding occurring in specific sections 
of the gastrointestinal tract. Vitamin B12 initially binds to the salivary R-binder (haptocorrins) in 
the mouth, which has high affinity for vitamin B12 under acid conditions (optimum pH <3) 
(Petrus et al., 2009). In the stomach, dietary vitamin B12 is released from proteins by pepsin, a 
proteolytic enzyme produced by gastric chief and parietal cells. However, the salivary R-binder 
protects vitamin B12 from acid hydrolysis (Petrus et al., 2009). Then, vitamin B12 binds to R-
binder and passes into the small intestine where the R-binder is hydrolyzed by pancreatic 
proteases, and the free vitamin B12 binds to the intrinsic factor (IF) secreted by the gastric 
parietal cells (Combs Jr, 1998, Stipanuk and Caudill, 2012). In the small intestine, little vitamin 
B12 is absorbed by passive diffusion (ca. 1%). The main mechanism of vitamin B12 absorption is 






multi-ligand apical membrane protein cubulin, which recognizes and binds the IF–vitamin B12 
complex, but not the unbound or free vitamin B12. The enterocyte internalizes the IF–vitamin 
B12 complex by endocytosis and the IF is degraded in the cytosol (Figure 1.1). Vitamin B12 then 
traverses the endothelial cell and enters the portal circulation. 
The intestinal absorption of vitamin B12 is limited by saturated rate of the proteins transports 
(Carmel, 2008). At doses of 3 μg, approximately 50% of the vitamin B12 will be absorbed, and at 
higher doses the net absorption decreases progressively (Carmel, 2011). 
Vitamin B12 is transported in the blood bound to the proteins transcobalamin (or transcobalamin 
II) and haptocorrin (or transcobalamin I). Transcobalamin carries only about 20-30% of the total 
circulating vitamin B12 because it has a very short life, and haptocorrin carries about 70-80% of 
circulating vitamin B12 (Combs Jr, 1998, Stipanuk and Caudill, 2012). In humans, vitamin B12 is 
mainly stored as 5’deoxyadenosylcobalamin (ca. 2-3 mg) in the liver, and as methylcobalamin in 
plasma. Excess of vitamin B12 is excreted via urine and bile. Generally, the enterohepatic 
circulation results in effective re-uptake of biliary vitamin B12 via the IF-mediated process 
(Combs Jr, 1998, Stipanuk and Caudill, 2012). 
The mechanism of absorption of vitamin B12 in ruminants has not been described in 
detail. The concentration of transcobalamin in bovine blood is similar to humans; however the 
binding capacity is lower in bovine transcobalamins (Polak et al. 1979).  
 
Mammals use vitamin B12 as a cofactor of two enzymes (Figure 1.2) (Kozyraki and Cases, 
2013). 
1- Methionine synthase (also called methyl-FH4 methyltransferase). By converting 






aminoacid methionine involved in several methylation reactions necessary for 
nucleotide, DNA, RNA and protein synthesis and to regenerate tetrahydrofolate. 
2- Methylmalonyl-CoA mutase. This mitochondrial enzyme participates in the catabolism 
of odd-chain fatty acids, branched amino acids, and cholesterol, to generate succinyl-
CoA.  
 
Vitamin B12 in the ruminant 
Ruminants do not have dietary requirements for vitamin B12 (NRC, 2001) and it is generally 
agreed that ruminal microorganisms produce enough vitamin B12 when cobalt is available in the 
diet (NRC, 2001). Synthesis of vitamin B12 in the rumen is dependent on a continuous supply of 
dietary cobalt, as microorganisms can synthesize the organic portion of the corrin nucleus in the 
presence of cobalt (Combs Jr, 1998). Cobalt dietary requirement for dairy cattle is 0.11 mg/kg of 
dry matter (NRC, 2001). As dietary cobalt increases, the ruminal microbes also produce an 
increasing amount of non-physiologically active analogs to vitamin B12, (NRC, 2001). 
In lactating cows, vitamin B12 is needed for propionate metabolism (gluconeogenesis), 
methionine synthesis, and folate metabolism. At the beginning of the lactation in dairy cows, the 
concentration of serum vitamin B12 is reduced due to the increased demands for lactation (Girard 
and Matte, 1999). Serum vitamin B12 concentration dropped from 5.7 ng/mL at 55 d prepartum, 
to 2.0 and 1.9 ng/mL at 7 and 120 d of lactation, respectively (Kincaid and Socha, 2007). Studies 
using both dietary supplements (Graulet et al., 2007, Girard and Desrochers, 2010) or 
intramuscular injections (Girard and Matte, 2005a, Preynat et al., 2009) of CN-CBL combined 
with folic acid, biotin or rumen protected methionine supplementation, resulted in increased of 






microorganisms is not enough to meet vitamin B12 requirements (Table 1.2). In addition, vitamin 
B12 concentration in milk was increased from 1.2 to 4.0 ng/ml when parental and dietary 
supplementation was used (Girard and Matte, 2005a; Graulet et al., 2007).  
A glass of milk from supplemented cows will cover 42% of adult human daily requirements for 
vitamin B12 (Girard and Matte, 2005a; Graulet et al., 2007). Therefore milk from supplemented 
cows with vitamin B12 has the potential to be an excellent source of vitamin B12 for human 
consumption. However, such production responses require high amounts of dietary vitamin B12 
(500 mg) in order to increase plasma concentration (Graulet et al., 2007) at levels similar to those 
observed after 10 mg vitamin B12 given by intramuscular injections. A study conducted in dairy 
cows equipped with cannulas in rumen and duodenum, determined that 80% of a dietary 
supplement of cyanocobalamin (CN-CBL) is degraded in the rumen and less than 25% of the 
amount of vitamin B12 bypassing the rumen is absorbed in the small intestine of dairy cows 
(Girard et al., 2009). Although there is evidence that a dairy cow needs vitamin B12 
supplementation for optimal performance, current dietary supplementations for vitamin B12 are 
















Structure and Functions 
 Free choline [2-hydroxy-N,N,N-trimethylethanaminium or (b-hydroxyethyl) 
trimethylammonium], (CH3)3N+CH2CH2CH2OH, (2-hydroxymethyl-trimethyl-ammonium) is a 
trimethylated, positively charged, quaternary, saturated amine that serves as precursor of several 
metabolites and is commonly grouped with the water-soluble B vitamins. Choline is a family of 
compounds present in cells as a free choline and within subunits of a macromolecule (e.g., 
phosphocholine in biological membranes) (Wurtman et al., 2010). Pure choline is a colorless, 
viscous, strongly alkaline hygroscopic liquid. Choline is soluble in water, formaldehyde, and 
alcohol and has no definite melting or boiling point (McDowell, 1989). The chloride salt of this 
compound, choline chloride, is produced by chemical synthesis for the feed industry. Choline 
chloride exists as white crystals very soluble in water and organic solvents. Aqueous solutions 
have neutral pH. The prominent biological relevance is derived from three methyl groups that 
enable choline chloride to serve as a methyl donor (Combs Jr, 1998).  
 
Distribution in food 
Zeisel et al. (2003) evaluated the choline content of 145 commonly consumed foods. Choline and 
choline metabolites determinations included free choline (Cho), phosphocholine (PCho), 
glycerophosphocholine (GpCho), phosphatidylcholine (PC), betaine, and sphingomyelin (SM). 
All raw and unprocessed foods contained some choline. Foods with the highest total choline 
concentration (mg/100 g) were: beef liver (418), chicken liver (290), eggs (251), wheat germ 






accounted for 95% of total choline in eggs and about 55-70% in meats and soybeans. In wheat 
germ, the predominant form was Cho (45%), while PC was the second most abundant form 
(30%). In general, whole fruits and vegetables contained about 5-40 mg total choline/100 g 
(Table 1.2). The amount of total choline in vegetables was stable during cooking process, but 
free choline decreased and PC increased when vegetables were boiled (Zeisel et al., 2003). In 
addition, finely minced processing in vegetables decreased the concentration of PC and increased 
Cho concentration, suggesting that phospholipase D was activated (Zeisel et al., 2003).  
 
Digestion, Absorption and Metabolism 
Digestion and absorption of choline vary depending on the specific choline ester (Stipanuk and 
Caudill, 2012). The absorption of free choline is mainly in the jejunum and ileum via a sodium 
dependent carrier-mediated transport that is saturable and substrate-specific (Stipanuk and 
Caudill, 2012; Garrow 2007). Free choline in the enterocyte is rapidly phosphorylated to PCho 
by the cytosolic enzyme choline kinase. In the nucleus, PCho is activated to CDP-choline in a 
CTP-dependent reaction by CTP-phosphocholine cytidyltransferase. The synthesis of PtdCho by 
the CDP-choline pathway is regulated by the rate-limiting enzyme CTP:phosphocholine 
cytidyltransferase (CCT). The decrease of PC levels or fatty acid /diacylglycerol concentrations 
increases the activity responds of CTP:phosphocholine cytidylyltransferase (CCT) enzyme in the 
nucleus high (Gehrig et al., 2009). Finally, CDP-choline is catalyzed by choline 
phosphotransferase to PC in the endoplasmatic reticulum. The new PC is then transported out of 
the cell via membrane lateral diffusion by vesicular transport or a protein carrier. 
An increase in choline supply in the small intestine increases the uptake of choline by the liver, 






for phospholipids synthesis (i.e phosphatidylcholine, sphingomyelin), whereas excess choline is 
converted to the methyl donor betaine (Fig. 1.3). In non-ruminants, the CDP-choline pathway is 
the main source of choline (Zeisel et al., 1991) but in ruminants because almost all dietary free 
choline is degraded in the rumen (Sharma and Erdman, 1989) this pathways is limited 
(Grummer, 2012).  
Choline can be synthesized endogenously by the enzyme phosphatidylethanolamine N-
methyltransferase (PEMT) that catalyzes the methylation of phosphatidylethanolamine to PC by 
the transfer of 3 methyl groups from S-adenosylmethionine (Cole et al., 2012). In non-ruminants, 
this enzyme accounts for ca. 30% of the PC made in hepatocytes (Vance et al., 1997). PEMT 
knockout mice have an absolute requirement for dietary choline and the deficiency of dietary 
choline in these mice results in a dramatic reduction of PC, accumulation of triglycerides in the 
liver, and death after 3-5 days (Vance et al., 1997).  
Although PEMT was detected in several tissues including brain and mammary epithelial cells, 
PEMT activity is quantitatively significant in the liver (Reo et al., 2002). The PEMT gene is 
estrogen-responsive in human and mouse hepatocytes (Resseguie et al., 2007). When deprived of 
dietary choline, almost 80% of men and postmenopausal women developed liver or muscle 
damage, whereas only 43% of premenopausal women developed such signs of organ dysfunction 
(Fischer et al., 2007). Therefore, from an evolutionary perspective, women during pregnancy and 
lactation can supply more choline from endogenous biosynthesis to support nervous system 
development in neonates (Fischer et al., 2010). 
A single nucleotide polymorphism in the sequence of the genes of PEMT and choline 






on a low choline diet, and they likely affect dietary requirements for choline (da Costa et al., 
2006). 
Although the product of both CDP-choline and the PEMT pathways is PC, the fatty acid profile 
of the PC molecules differs between pathways synthesis. The combination of esterified fatty acyl 
moieties in the PC molecules as defined by at the sn -1 and sn -2 positions of the 
glycerophosphate backbone, is specific of the synthesis by both pathway. An study in human and 
mouse livers using radioisotopes of PC metabolic labeling found that PC produced via the 
PEMT-mediated phosphatidylethanolamine (PE) pathway was enriched in long-chain PUFAs 
such as DHA (22:6n23) and arachidonic acid (ARA; 20:4n26) (DeLong et al., 1999). In contrast, 
PC generated by the cytidine diphosphate (CDP)–choline pathway is enriched in di- and mono- 
unsaturated fatty acids such as linoleic acid (18:2n2) and oleic acid (18:1n2). The portion of 
PtdCho species containing DHA (pmol PtdCho-DHA/nmol PtdCho) is useful as a surrogate 
marker for in vivo hepatic PEMT activity in humans (da Costa et al., 2011). 
 
Physiological Functions of Choline 
The physiological functions of choline include lipid biosynthesis and metabolism, membrane 
formation, neurotransmission, and 1-carbon metabolism. Choline is present in bile at high 
concentrations (95% as PC). Particularly, PC acts directly on the intestinal mucosa to restore its 
protective hydrophobic lining, otherwise under bile salts attack (Barrios and Lichtenberger, 
2000). Approximately 95% of biliary PC are reabsorbed by the intestine and incorporated into 
chylomicrons. Although newly synthetized PC contributes only a small percentage of biliary PC, 






membranes and thereby enable the synthesis of PC close to the biliary excretion site (Sehayek et 
al., 2003). 
Phospholipids are the structural elements of biological membranes, and are critical for cellular 
division and transmembrane signal transduction (Combs Jr, 1998). The main phospholipid 
constituent of the bilayer membrane is PC. In the cell membrane, most of the 
phosphatidylcholine is located in the outer leaflet of the lipid membrane. Sphingomyelin and 
lysophosphocholine are also found in all membranes within the cell, but at much lower levels 
than PC. Like PC, the sphingomyelin and lysophosphocholine content in the outer leaflet of the 
plasma membrane is greater than that in the inner leaflet. 
The main phospholipid on the surface monolayer of VLDL particles is PC which is essential for 
packaging and transporting the lipids delivered from the diet as chylomicron and non-esterified 
fatty acids into lipoprotein lipids for export to extra hepatic tissues. 
Choline is required for several processes in the brain. It is needed for neurotransmitter synthesis 
(acetylcholine), essential for synapsis formation and myelation (Micheau and Marighetto, 2011). 
Studies in rodents have shown that the availability of choline in utero and during the post-natal 
period produces important changes in neural systems that underlie learning and memory and 
exerts life-long effects on cognitive functioning (Zeisel, 2012). 
The importance of dietary methyl donors, and in particular choline, requires a broad 
understanding of the interrelationship and balances of one carbon metabolic pathways. Figure 1.4 
integrates metabolic pathways involved in one carbon metabolism. 
The endogenous biosynthesis requires the methylation of PE to PC catalysed by PE-N-
methyltransferase (PEMT), which requires the methyl donor S-adenosylmethionine (SAM) (Reo 






by S-adenosylhomocysteine (SAH), and the ratio of SAM:SAH (an indicator of methylation 
capacity) therefore affects the activity of PEMT (Vance et al., 1997). Since there is no storage 
for free choline, at cellular level choline is oxidized to betaine (Garrow, 2007). The increase of 
free choline at the small intestine can saturate and inhibit choline kinase, the first enzyme in the 
CDP-choline pathway and then, the majority of choline then enters the mitochondria where it is 
oxidized to betaine in a two-step reaction (Stipanuk and Caudill, 2012).  
In ruminants, only small quantities of methyl group nutrients (choline, folate and 
methionine) are available from the diet and methionine synthase assumes a much more important 
role (Neill et al., 1979). Methionine synthase is responsible for the de novo synthesis of 
methionine from one-carbon units furnished by 5-methyl-tetrahydrofolate (Pinotti, 2012). In 
studies on interchangeability of choline and methionine in lactating goats by infusing 
radiolabelled choline and methionine, Emmanuel and Kennelly (1984) concluded that 28% of 
methionine was used for choline synthesis. In dairy ruminants, methionine is also the first 
limiting amino acid required for transmethylation reactions and milk protein synthesis (Lobley et 
al., 1996). Vitamin B12 is a cofactor for methionine synthase to generate methionine when a 
methyl group from 5-methyl-THF is transferred to homocysteine. If one carbon-unit from the 
folate metabolism is available, vitamin B12 supports PEMT activity by reducing homocysteine 
level and by increasing methionine levels, resulting in an increased SAM: SAH ratio, and thus 








Analytical methods for choline  
Several analytical methods have been proposed to identify and quantify choline metabolites with 
different performance and specificity.  
Total choline can be determined by the quantification/addition of all free and esterified choline 
isomers, or by the hydrolysis of the metabolites before quantification of free choline. The 
digestion or hydrolysis is not a preferred method as it loses information on the individual 
choline-containing compounds. 
Currently, the only widely accepted quality control assay for total choline determination is the 
AOAC 999.14 method, modified for various matrices (Rader et al., 2004). The method consists 
in digesting the sample in acid or alkali to release most of the choline, followed by an enzymatic 
hydrolysis using phospholipase D. Then, the free choline moiety is exposed to choline oxidase 
with subsequent liberation of hydrogen peroxide. In the presence of peroxidase, phenol is 
oxidized and a quinoneimine chromphore is formed with 4-aminoantipyrine. Both enzymatic and 
color-forming reactions are synchronized to occur concurrently. Absorbance is measured at 505 
nm, corrected with a choline blank, and then quantified using a calibration curve. This method is 
relatively simple and does not require specialized or dedicated instrumentation. Moreover, the 
method was assessed in a collaborative study including 29 laboratories prior to reaching official 
status by AOAC (Phillips, 2012). The limitation of this methodology is that it does not quantify 
the acid-resistant of PCho (Phillips, 2012). 
The measurement of choline-related compounds and phospholipids is important to understand 
the biological relevance of specific isomers. Various analytical techniques were developed for 
the quantification of some of these choline moieties, including 
31
P nuclear magnetic resonance 
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spectrometry (GC/MS) (Pomfret et al., 1989), liquid chromatography coupled with evaporative 
light scattering, fluorescence, or mass spectrometry (Sala Vila et al., 2003, Zhao et al., 2011). 
Nuclear magnetic resonance (
31
P NMR) has been used to quantify phospholipids including PC, 
phosphatidylethanolamine, and phosphatidylinositol in different biological matrices (Klein et al., 
2010, Brinkmann-Trettenes et al., 2012). Its main drawback is that this method uses chemical 
shifts observed for phosphorus-containing molecules, so it cannot quantify species without P 
such as choline (Zhao et al., 2011). Moreover, although it is a very convenient method requiring 
little sample preparation, it cannot differentiate fatty acid chains in choline esters (e.g., PC; Zhao 
et al., 2011). 
Previous methods using GC-MS (Pomfret et al., 1989) and thin-layer chromatography (Dickens 
and Thompson Jr, 1982) are time-consuming and have relatively low sensitivity. For instance, 
despite of the fact GC-MS successfully quantified choline, PCho, GPCho, PC, and SM, as well 
as AcCho and LPC, Pomfret et al. (1989) suggested that only 40 samples could be analyzed in a 
single week, which it is not practical for routine use in the determination/quantification of total 
choline in foods and dietary supplements (Phillips, 2012). Koc et al. ( 2002) developed a LC-MS 
technique using isotope dilution MS (IDMS) to analyze choline compounds. This method was 
utilized in the analysis of 630 food items to generate a USDA database (Howe et al., 2004). 
Although improved, this method still requires pre-fractionation of the extracted samples into an 
aqueous phase containing betaine, choline, GPC, PCho and a chloroformic phase containing 
phosphatidylcholine and sphingomyelin. The two phases are analyzed in two LC runs using the 
same mobile phase but different gradients. 
Recently, a new analytical method was developed and validated to simultaneously quantify all 






the diversity of polar head groups found in phospholipid molecules and the polarity of choline-
related compounds, a separation scheme based on hydrophilic interaction chromatography 
(HILIC) was used to determine either a limited number of water soluble choline compounds or 
phospholipids classes such as PC and SM.  In addition, mass spectrometry was added as an 
additional dimension of separation based on mass-to-charge ratio. The molecular weight and 
fragment ion information provided by the mass spectrometer made it possible to differentiate 
choline metabolites with various combinations of fatty acyl substitutes within the PC or LPC 
fractions (Zhao et al., 2011). 
 
Choline in the ruminant 
Best and Huntsman (1930) demonstrated that choline is required in the diet by showing that a 
choline-deficient diet caused fatty liver disease in rodents. The essentiality of choline in the diet 
was determined for several mammalian species such as rat, dog, human and production animals 
namely poultry and swine (Stipanuk and Caudill, 2012). However, the extensive degradation of 
dietary choline in the rumen and the endogenous choline synthesis made it difficult to estimate 
choline requirements in ruminants (NRC, 2001). 
Plant and animal tissues as well as feedstuffs derived from them contain free choline and 
choline-containing phospholipids (Pinotti et al., 2002). Choline is present mainly as a PC 
(lecithin) in feed ingredients and crude unprocessed fat sources, while in compound feeds, 
choline chloride is usually added as a supplement. Choline in feed (predominantly lecithin) and 
supplemental choline chloride were shown to be extensively degraded (from 79 to 99%) in the 
rumen (Sharma and Erdman, 1989). In sheep equipped with rumen fistula and abomasal cannula, 
76% of [
14








C phosphatidylcholine in the rumen was initially rapidly broken down (<3 h). 
Approximately 28% of the radioactivity remained constant in the rumen, suggesting that part of 
the dietary choline was incorporated into protozoa PC (Neill et al., 1979). Only 0.07% of the 
administrated [
14
C] –choline dose was found in the liver and only traces in other tissues (Neill et 
al., 1979). Therefore, choline present in the diet of ruminants largely as phosphatidylcholine 
from plant membranes is rapidly released and degraded in the rumen by the microbes to 
trimethylamine and ultimately methane (Neill et al., 1978, Neill et al., 1979).   
In dairy cows, the output of choline compounds in milk is high but the dietary availability of 
choline is still low and precursors from the de novo pathway may be limiting, especially at the 
onset of lactation (Baldi and Pinotti 2006). Several studies showed that 50 to 60% of the 
transition cows (3 weeks before and after lactation) experience moderate to severe fatty liver 
disease at the onset of lactation (Bobe et al., 2004), which is a clear symptom for choline 
deficiency. Based on those considerations, microencapsulated technology has been developed to 
protect choline from degradation in the rumen. The formulated microcapsule allows controlled 
release of the supplement into the small intestine, thereby improving its effectiveness and 
ensuring optimal dosage. Commercially available rumen protected choline, containing 28–50% 
choline chloride, was found to protect ca. 85% of the choline from rumen degradation in vitro 
(Pinotti et al., 2002). These products can be added directly to the compound feed or administered 
as a top-dress.  
Several studies were conducted to elucidate the effect of rumen-protected choline (RPC) 
supplementation on transition dairy ruminants. RPC supplementation reduced triacylglycerol 
accumulation in the liver and increased milk yield and milk fat concentration, consistent with the 






lipoprotein synthesis, i.e. VLDL, and assembly in liver was greater in cows supplemented with 
RPC during the transition period (Goselink et al., 2012). A study conducted in dairy cows from 
25 days prepartum to 80 days postpartum, reported that cows fed with RPC showed reduced 
incidence of clinical ketosis, mastitis, and morbidity (Lima et al., 2012). The supplementation 
during transition period on dairy cows with rumen-protected choline (20 g of choline chloride) 
increased plasma levels of choline-containing phospholipids and folates, from 127 to 171 mg dL
–
1
 and 6.74 vs. 9.68 ng mL
–1
, respectively  (Baldi et al., 2004). Therefore, RPC supplementation 
not only increased choline availability but also optimized methyl group metabolism. The 
increase in plasma folates was attributed to a sparing effect of choline on one-carbon 
metabolism. 
The supplementation of choline plays a significant role in the transition cow but requirement for 
choline may continue throughout lactation. At the mammary gland level in dairy ruminants, 
choline plays a major role in lipid metabolism, particularly in lipid transport and milk fat 
secretion. When availability of choline from natural or sources or synthetic is restricted, the rate 
of choline-containing phospholipids synthesis decreases, affecting lipoprotein lipid transport 
(Pinotti et al. 2002). Therefore, it is necessary to define choline requirements and feeding 
guidelines for choline on dairy cows. 
The choline content of milk is a useful measure of choline status. The milk choline secretion 
increased from 1.95 to 3.95 g/d when dairy cows were infused during a 14-d period with 60 g/d 
of choline chloride (Deuchler et al., 1998). In addition, when dairy cows were abomasally 
infused with 0, 25, 50, and 75 g/d of choline chloride, the total choline in milk increased from 
2.56 to 3.82 g/d (Deuchler et al., 1998). Therefore, the total choline concentration in milk is a 






Choline in milk 
Despite the lack of dietary-derived choline in the ruminant, milk and dairy products are an 
important source of choline in the human diet. One cup of retail milk (2% fat) is expected to 
provide approximately 40 mg of choline (Howe et al., 2004), which represents nearly 10% of an 
adult woman’s daily choline requirement (Zeisel and Da Costa, 2009). The major choline-
containing compounds in bovine milk are free choline, glycerophosphocholine and 
phosphatidylcholine (Patterson et al., 2008). The total choline content is similar in both, whole 
and skim milk (16.40 mg/100g vs 15.63 mg/100g, respectively). However, PC concentration is 
the only metabolite greater in whole milk than skim milk (1.15 mg/100g vs 0.75 mg/100g, 
respectively) whereas the other choline metabolites are in similar concentrations for both milks. 
Phospholipids account for about 1% of the total bovine milk lipids (Bitman and Wood, 1990), 
and about 60% of these are found as part of the milk fat globule membrane (MFGM), with the 
rest located in the residual MFGM material found in the milk serum phase (Keenan, 2001). 
Distribution of the fatty acids and the head groups of the individual phospholipids determine the 
physical characteristics of the dairy products and the MFGM structure. The degree of saturation 
and the length of the fatty acids of phospholipids play a key role in the fluidity/rigidity of the 
MFGM surrounding the liquid lipid core of the fat globule (Singh, 2006). Phospholipids in milk 
are easily hydrolyzed or oxidized (Singh, 2006). Upon processing (e.g. homogenization, heat 
treatment), the MFGM is altered and loses some phospholipids, which will consequently 
influence its functional properties (Keenan, 2001). It is uncertain whether this occurs due to heat 
treatment and/or during agitation when membrane material desorbs because of coalescence of fat 







Net flux of the nutrients across the gastrointestinal tract and the liver  
The stomach allows extensive digestion, absorption and metabolism of dietary nutrients before 
they reach the small intestine, where further digestion and absorption occurs. In vivo 
measurements of the relative contribution of stomach or post-stomach tissues to the absorption or 
metabolism by the entire gastrointestinal tract, have been limited to measurements of nutrient 
disappearance from digestion in cannulated animals (Reynolds and Huntington, 1988). These 
measurements did not account for the extensive metabolism of nutrients by the gut tissue which 
determined their net appearance in the hepatic portal vein.  At the small intestine, the digestion 
products are transported into the enterocyte where some nutrients are taken up for maintenance 
of the structural and functional integrity of the small intestinal mucosa or enter to portal blood or 
the lymphatic vessels for passage and delivery to the rest of the body (Stipanuk and Caudill, 
2012). 
The portal vein is a vessel that conducts blood from the gastrointestinal tract and spleen to the 
liver. This blood is rich in nutrients that were extracted from the ingested food and will be 
metabolized in the liver. Therefore, blood sampled at the portal vein compared with arterial 
blood represents the cumulative effects of metabolism across a range of diverse tissues (Cronjé 
and Boomker, 2000). For that reason, the use of chronic indwelling catheters in appropriate 
blood vessels has been successful in obtaining in vivo measurements of net flux of metabolites 
across gastrointestinal tissues (Figure 1.4). Moreover, the combination of arterial–venous (A-V) 
differences, blood flow and measurements including isotopic extraction, provides invaluable 
insight into the quantitative metabolism of absorbed nutrients by the splanchnic tissues (Dijkstra 
et al., 2005). The technique involves the implantation (under general anesthesia) of catheters in 






concentration of metabolites is virtually the same in all arteries (Dijkstra et al., 2005). As the 
arterial sample is critical, the carotid artery is often elevated to a subcutaneous position to allow 
insertion of a temporary catheter (Huntington et al., 1989). This methodology allows getting 
direct, quantitative information on nutrient absorption from the gut, including identifying 
limitations on rate and extent of digestion and absorption. Indeed, experiments altering diet 
composition and feeding protocols, obtain information needed to minimize digestive and 
absorptive losses, thereby improving efficiency of nutrient uptake from the gut (Huntington, 
1982).  
It has been demonstrated that the plasma flow is affected by feeding time, body weight and 
physiological state (e.g., pregnancy) (Katz and Bergman, 1969, Huntington, 1982). For instance, 
portal blood flow in cows ranged from 1.14 to 2.65 liters/h per kg of body weight (Huntington, 
1982). Also, fasting significantly decreased the mean rates of blood flow in sheep (Katz and 
Bergman, 1969). Estimation values for blood flow and metabolite concentration for 24-h is ideal 
but rarely done. Hourly feeding reduces but does not eliminate variation over 24 h, depending in 
part on the level of intake, and may well distort ‘normal’ metabolism (Dijkstra et al., 2005).  
The net flux of a nutrient is calculated as follows: 
 
Net flux of the compound = (Pm - Am)*PBF 
 
Where  
PBF is the portal blood flow (l/h);  
Pm is the Portal concentration of the metabolite (μmol/l) 






If Pm > Am, net flux of the metabolite is positive (there is net release or absorption into the 
venous blood).  
If Pm < Am, net flux of the metabolite is negative (there is net uptake or removal from the 
arterial blood). 
 
Para-aminohippuric acid (PAH) can be used as an indicator of blood flow because it is not 
metabolized and it is rapidly excreted by the kidney (Dijkstra et al., 2005). Other techniques have 
been described for measuring blood flow, including electronic methods using a probe around a 
vessel such as the portal vein or hepatic artery or an electromagnetic or ultrasound/Doppler shift 
detector. These methods provide instant and time-averaged flows but are not feasible in cattle, 
because of difficulties in probe placement on the portal vein (Lindsay and Reynolds, 2005). The 
method of PAH involves infusion into the blood at one point and measurement of concentration 
downstream (Dijkstra et al., 2005). Blood flow is calculated by determining the difference in 
indicator dye concentration, PAH, between the target vessel and the peripheral circulation 
relative to the dye infusion rate (Isserty et al., 1998):  
Fpv= I/ Cpv-Ca 
Where, Fpv is the rate of blood flow (ml/min) in the portal vein; I is the infusion rate of PAH 
(mg/min); and Cpv and Ca are the concentrations of PAH (mg/ml) in the portal venous and 
arterial blood, respectively.  
The concentration of PAH in the blood should remain constant after a period of continuous 
infusion in which the PAH is allowed to equilibrate with the extracellular fluid, because PAH is 
rapidly excreted by the kidney (Katz and Bergman, 1969). The PAH is infused continuously at 






1989). Simultaneous blood samples are taken from catheters in the portal vein, hepatic vein and 
artery to form a sample set. 
Huntington et al. (1989) chose to insert catheters into two mesenteric veins and to infuse PAH. 
Other anatomical sites for PAH infusion were tried (e.g., aorta caudal) but the higher blood 
pressure in the aorta compared with the mesenteric veins, created a strong resistance to infusion 
and resulted in expansion of the inner volume of the infusion lines (Ortigues et al., 1994). 
Another alternative is infusing PAH through the mesenteric and ruminal veins, both at the same 
time. This technique reduces the variability compared to mesenteric-only infusions (Ortigues et 
al., 1994). However, high incidence of phlebitis was observed in sheep when the ruminal vein 
was catheterized and infused with PAH (Webster and White, 1973). 
The concentration of PAH varies with the size of animals infused. Animals weighing 250 kg or 
less can be infused with 7 to 10 % PAH (wt/vol) at 1 ml/min, but larger animals require 10 % 
PAH at 2 ml/min, to provide an adequate blood concentration. The goal is to achieve 20 mg/L in 
arterial blood, to obtain a reliable concentration difference for calculation of blood flow. 
Incomplete mixing in blood vessels may result in over- or under-estimation of the A–V 
difference and error in blood flow estimation (Huntington et al., 1989). Therefore, mesenteric 
infusion catheters should be established with their tips as far as possible from portal sites, and 
portal vein sampling catheters should be inserted downstream, where turbulence helps to mix 
portal blood as it is delivered to the liver. In addition, the use of PAH for measuring blood flow 
is dependent on an appropriately placed mesenteric vein catheter for PAH infusion (Dijkstra et 
al., 2005). 
The PAH has to be dissolved in sterile saline solution and NaOH, titrated to pH 7.4 with HCL 






compared to other markers (e.g., bromophthalein, BSP) (Katz and Bergman, 1969). However, 
chemical alteration occurred in the liver (acetylation) and Katz and Bergman (1969) suggested 
that the samples should be deactylated before analysis.  
 
Portal drained viscera applications in choline and vitamin B12 studies 
Choline and water soluble vitamins (biotin, folic acid, niacin, pantothenic acid, pyridoxine, 
riboflavin, thiamin, and vitamin B12) requirements are generally considered to be met through 
synthesis by ruminal microorganisms (NRC, 2001). However, over the last 50 years, milk and 
milk component yields increased drastically. Therefore, requirements increased accordingly and 
synthesis by ruminal microflora alone may not be sufficient to meet these increased needs 
(Girard and Matte, 2005b). True deficiencies of these vitamins are rare in ruminants but their 
supply might be limiting optimal performance. Therefore, information on bioavailability and 
ruminal synthesis, for most water-soluble vitamins it is needed to determine requirements (NRC, 
2001).  
Techniques used to obtain in vivo quantitative measurements of nutrients absorbed in lactating 
dairy cows include gut cannulation, multi-catheterization of the hepatic portal vasculature, and 
isotope dilution (Reynolds et al., 1994). Placement of cannula in rumen cannulation and 
duodenum enable measurements of ruminal digestion and dynamics, microbial protein synthesis, 
and the flow of microbial and dietary constituents to the small intestine. With the addition of 
multi-catheterization techniques for measurements of nutrient absorption, it is possible to 
estimate the net movement of metabolites across sections, including the mesenteric-drained 
viscera or the rumen or the net flux of nutrients across the portal-drained viscera (PDV) tissues. 






to varying degrees or in divergent directions (Reynolds et al., 1994). The interpretation of net 
PDV flux measurements is further complicated by the fact that nutrients enter and leave the 
system via the intestinal lumen, blood, and lymph. Nevertheless, net nutrient appearance across 
PDV represent the amounts of nutrients absorbed into blood available to the rest of the body after 
PDV metabolism is subtracted (Reynolds et al., 1994).  
The net flux of vitamins from the rumen is the difference between the amount absorbed from the 
lumen and the amount used (or stored) in cells of the rumen wall. In a study on cows equipped 
with rumen cannula and catheter in the ruminal vein, no detectable net flux of folates and 
vitamin B12 across the rumen wall was detected before the infusion of vitamins. When high doses 
of folates and vitamin B12 were infused, both reached the blood circulation across the rumen wall 
in low concentrations, especially for vitamin B12 (Girard et al., 2001). Indeed, when cows were 
equipped with rumen and duodenal cannula, only 20% of supplemented cyanocobalamin was 
recovered at duodenal level (Girard et al., 2009). Therefore, 80% of dietary supplement of CN-
CBL was degraded in the rumen. Moreover, low dietary choline efficiency was found when U-
14
C
 labeled grass was introduced into the rumen of cannulated sheep, as the [14
C
] PC was 
rapidly broken down (~75%) (Neill et al., 1979). 
The net flux of vitamins and choline at PDV level is the difference between the intake by the 
intestinal cells and the release to the portal vein. When cows were supplemented with CN-CBL 
(500 mg), the net flux across PDV was positive after 24hr with a slow release (49.3% was 
released during 4–10 h post-ingestion and 34.9% 20–24 h post-ingestion) and a biphasic 
absorption pattern (Girard et al., 2001). The PDV net flux of choline when choline is 






and hepatic venous catheters, will provide an understanding of vitamin limitations and 
absorption in the lactating dairy cow.  
 
Summary and objectives 
 
There has been renewed interest in one-carbon metabolism, prompted by recent reports 
indicating that modest dietary inadequacies of choline and vitamin B12 can contribute to 
important diseases such as fatty liver diseases in the lactating dairy cow. The overall objective of 
this thesis was to determined choline and vitamin B12 absorption and utilization patterns in 
lactating dairy cows. This thesis comprised three objectives.  
1) Evaluate the efficacy of casein and whey protein as delivery methods to improve intestinal 
absorption of vitamin B12 in cows.  
2) Establish a methodology to measure choline and its metabolites in blood and milk and 
determine changes in their relative proportions occurring during early, mid and late lactation.  
3) Determine the bioavailability of abomasally infused choline and rumen protected choline and 
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Table 1.1: Sources of vitamin B12 in foods 
Food Vitamin B12 μg/100 g 
Beef 1.9-3.6 
Beef kidney 38 
Beef liver 69-122 
Milk 0.4 
Yogurt 0.1-0.6 





 Adapted from Combs Jr ( 2012) 
 
 
Table 1.2: Choline metabolite concentrations (mg/100 g) in common foods
1
 
 Choline GPC PCho PC SM Betaine Total 
choline
2 
Beef liver 56.67 77.93 11.77 247.75 24.10 6.34 418.22 
Chicken   
liver 
47.87 8.80 4.86 213.70 14.8 12.86 290.04 
Eggs 0.62  0.60 0.61 238.43 10.74 0.59 251.00 
Pork 2.19 1.18 22.51 70.45 6.42 3.54 102.76 
Bacon 12.06 14.52 2.68 85.58 10.05 1.57 124.89 
Milk 2% 2.82 9.98 1.58 1.15 0.87 0.94 16.40 
Soybean 47.27 2.92 1.12 64.56 ND 2.08 115.87 
1 
Adapted from Zeisel et al., 2003 
Betaine (Bet), free choline (Cho), phosphocholine (PC),  glycerophosphocholine (GPC),  
sphingomyelin (SM), phosphatidylcholine (PtC) 
2











Table 1.3: Summary of studies on effects of vitamin B12 on milk production and milk 
composition on the lactating dairy cow 
Reference Lactation stage Dose 
(mg/d) 



















i.m. 1d/wk No differences within treatments 
Elliot et al. 
(1979) 
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Means within a column within the same study among treatments with different superscripts 
differ (P < 0.05). 
xy
 Means within a   column within the same study among treatments with different superscripts 













Table 1.4: Summary of studies on effects of rumen-protected choline (RPC) on milk 
production and milk composition on the lactating dairy cow
 1
 
Reference Lactation stage RPC 
(g/d) 
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Continued Table 1.4 
Reference Lactation stage RPC 
(g/d) 
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Davidson et al. 
(2008) 
Primiparous 
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 Adapted from Benoit S. 2009. 
abc 
Means within a  column within the same study among treatments with different superscripts 











Figure 1:1: Absorption and processing of dietary vitamin B12. IF, intrinsic factor; MRP1, multi 








Figure 1.2: Cellular uptake and metabolism of cobalamin (Cbl). OH-Cbl, hydroxycobalamin; 
















Figure 1.3: Choline and vitamin B12 on one carbon metabolism pathways. CDP-Choline, 
cytidine diphosphate-Choline; DMG, dimethylglycine; PC, Phosphatidylcholine; PCho, 
Phosphocholine; SAH, S-adenosylhomocysteine; SAM, S-adenosylmethionine.; TC, 








Figure 1.4:  Scheme of the siting of catheters (dash red lines) in splanchnic studies in dairy cows. 
Adapted from (Dijkstra et al., 2005). The catheter at portal vein is located  3 to 7 cm craniad to 
the connection of the liver. The catheter at hepatic vein was located 2 to 6 cm from the lateral 







CHAPTER 2: CASEIN AND WHEY PROTEINS AS DELIVERY METHODS FOR 





























This chapter is a lightly revised version of a manuscript by V. M. Artegoitia, M. J. de Veth, F. 
Harte, D. R. Ouellet, C. L. Girard, The use of “our” in this chapter refers to my co-authors 
and I. My primary contributions to this paper include (1) the sample preparation, (2) the 




Improving vitamin B12 absorption is important for optimal performance in dairy cows and for 
increasing vitamin B12 concentrations in milk for human consumption. However, 80% of a 
supplement of synthetic vitamin B12, cyanocobalamin (CN-CBL), is degraded in the rumen of 
dairy cows and only 25% of the amount escaping destruction in the rumen disappears in the 
small intestine. The objective of this study was to evaluate the efficacy of casein and whey 
proteins as delivery methods for CN-CBL in solution to increase intestinal absorption of vitamin 
B12 in cows measuring portal drained viscera (PDV) flux. Four multiparous lactating Holstein 
cows (236 ± 17 DIM) equipped with a rumen cannula and catheters in the portal vein and a 
mesenteric artery were used in a randomized cross-over design. They were fed 12 equal meals 
per day to maintain steady-state. On experimental days, they received a post-ruminal bolus of: 1) 
CN-CBL alone (0.1g; CA), 2) CN-CBL (0.1g) + casein (10 g; CC) or 3) CN-CBL (0.1g) + whey 
proteins (10 g; CW). After the bolus, blood samples were taken simultaneously from the 2 
catheters every 15 min during the first 2 h and then every 2 h until 24 h post-bolus. Milk yield, 
DMI, arterial and PDV flux of vitamin B12 were analyzed by the MIXED procedure. Milk yield 
and DMI were not affected by treatments. Arterial plasma concentrations of vitamin B12 
increased when CN-CBL was infused with dairy proteins (average 408 pg/ml, CC and CW) 
compared with  CA (323 pg/ml). On average the PDV net flux of vitamin B12 was positive 






min after the bolus and decreased rapidly thereafter. The PDV net flux of vitamin B12 during the 
24 h period following the bolus of vitamin was greater when the vitamin was given in solution 
with casein (CC, 4 μg/h) whereas the PDV net flux of vitamin B12 was negative for CA and CW 
(-25 μg/h and -19 μg/h, respectively). Only 0.74% of the total amount of vitamin B12 infused 
post-ruminally reached the portal blood within the first 45 min and then there was no further 
release until 24 h after the bolus. The present results suggest that CN-CBL given with casein 
increased vitamin B12 absorption as compared to CN-CBL given alone. For practical applications 
of our findings, development of a casein-based formulation may improve CN-CBL absorption in 
dairy cows. 
Key words: Cyanocobalamin, bioavailability, vitamin B12, dairy cow 
Introduction 
Bacteria present in the rumen synthesize vitamin B12 and unless dietary Co supply is inadequate, 
the amount of vitamin B12 produced in rumen is sufficient to prevent apparition of deficiency 
symptoms (NRC, 2001). However, supplements of vitamin B12, intramuscular injection (10 
mg/d) or oral dose (500 mg/d),  given to dairy cows in early lactation combined with folic acid 
supplements, improve lactational performance and metabolic efficiency, suggesting that rumen 
microbial synthesis might not be always sufficient to optimize animal performance (Girard and 
Matte, 2005, Preynat et al., 2009). However, under commercial conditions, systematic use of 
intramuscular injections of the vitamin is not practical whereas 80% of a dietary supplement of 
the synthetic form of vitamin B12, cyanocobalamin (CN-CBL) is degraded in the rumen and less 
than 25% of the amount of vitamin B12 bypassing the rumen is absorbed in the small intestine of 






Previous studies in pigs estimated the bioavailability of dietary vitamin B12 using portal 
drained viscera (PDV) flux (Matte et al., 2010, Matte et al., 2012).The cumulative net PDV 
fluxes of vitamin B12 after ingestion of meals supplemented with 44 and 71 μg of CN-CBL 
without dairy protein in the diet were not different from 0 (Matte et al. 2012) However, when 
vitamin-free casein  was present in the diet the mean net PDV fluxes of vitamin B12  after boluses 
of 25 and 250 μg of dietary CN-C L were positive at 2.4 and 5.1 μg, respectively, and differed 
between doses (Matte et al., 2010) Therefore, milk proteins might be an approach to increase the 
level of absorption of vitamin B12. 
The objective of this study was to determine the efficacy of casein and whey proteins as 
delivery methods for CN-CBL in solution to increase intestinal absorption in dairy cows estimate 
by measuring porto-arterial difference and calculating PDV flux of the vitamin.  
Materials and Methods 
Animals were cared for according to the recommended Code of Practice for the Care and 
Handling of Dairy Cattle (2009) and the guidelines of the Canadian Council on Animal Care 
(CCAC, 2009). Four multiparous lactating Holstein cows (236±17 DIM and averaging 708 kg ± 
89 kg of BW), equipped with a rumen cannula and chronic indwelling catheters in the portal and 
2 mesenteric veins as well as in a mesenteric artery (Huntington et al., 1989) at least five months 
before the start of the experiment, were used. The catheters were exteriorized individually over 
the paralumbar shelf and spine. The right carotid artery was surgically raised to a subcutaneous 
position to allow access to arterial blood if the catheter placed in a mesenteric artery failed. In 
cases both arterial catheters failed, an auricular artery was used. Cows were housed in a tie-stall 
barn with free access to water under 16 h of light per day (0500 to 2200 h) and were fed in the 






intervals) by automatic feeders (Ankom, Fairport, NY) at 95% of their voluntary feed intake 
measured the week before the start of the study. Feed intake and refusals, when present, were 
weighed and recorded daily. Cows were milked twice a day (0700 and 1900 h). 
The cows were randomly assigned to 1 of 3 treatments in a cross-over design with 1 d 
and 3 d of wash-out between periods 1 and 2 and 2 and 3, respectively. The treatments were a 
post-ruminal bolus infusion (Vicini et al., 1988) of  60 mL of the following solutions: 1) CN-
CBL alone (0.1g; CA), 2) CN-CBL (0.1g) + casein (Casein acid hydrolysate vitamin free, Sigma, 
St-Louis, MO); 10 g; CC) and 3) CN-CBL (0.1g) + milk whey protein isolate (Hillmar
TM 
9400 
whey protein isolate, Canada Colors and Chemicals Ltd, St-Laurent, QC, Canada); 10 g; CW). 
Assuming that 1 μmole of CN-C L links to 1 μmole of casein (molecular weight between 19 
and 23 mg per μmole), linking 73.8 μmoles of cyanocobalamin should require 73.8 μmoles of 
casein (approximately 1.4-1.7 g caseins). Using 10 g of casein should assure that milk protein is 
well in excess of cyanocobalamin. The same weight of whey proteins was used. The post-
ruminal bolus infusion of 60 mL was given in less than 60 s and was followed by a similar bolus 
of water. 
All feed ingredients were sampled at the beginning of the study and frozen at -20°C until 
analysis. Samples were dried, ground and analyzed for DM and CP  (AOAC, 2000), ADF and 
NDF (Ankom200 fiber analyzer, Ankom Technology Corp., Fairport, NY) and cobalt 
(inductively coupled plasma emission spectrometry) (Agri-Food Laboratories, Guelph, ON, 
Canada).  
Starting 30 min after the post-ruminal infusion, blood samples (6 mL) were 
simultaneously taken from the portal vein and an artery every 15 min for the first 2 h and then, 






were put in Vacutainer tubes with EDTA (Becton Dickinson Inc, Franklin Lakes, NJ), the tubes 
were then placed on ice until centrifuged (2000 × g for 10 min at -4°C) and plasma was stored at 
–20 °C. Vitamin B12 in plasma was analyzed in duplicate by radioassay with a commercial kit 





MP Biomedicals, Diagnostics Division, Orangeburg, NY). 
Porto-arterial difference of CN-CBL across portal drained viscera was calculated as 
described by Girard et al. (2001) for each sampling time.  Blood flow was estimated based on 
values obtained from the same cows fed the same diet in a previous study (Maxin, personal 
communication) according to the following equation,:  
                      
Where γ is the average blood flow (l/h) and DMI is dry matter intake (kg/d).  
A positive net flux indicates a release by the tissues into the portal vein whereas a 
negative flux indicates an uptake by the tissues.  
All variables were analyzed as a cross-over design using the MIXED procedure (SAS 
version 9.3 Institute Inc., Cary, NC, USA) according to the following model: 
Yijkl = µ + Pi + Bj + Pi(cowk) + Tl + BTjl + εijkl 
where Yijkl indicated the dependent variable; µ was the overall mean; Pi, the effect of period; Bj, 
the effect of treatment, and Tl, the effect of time. The errors terms were Pi(cowk) used to test the 
main effects (error a) and εijkl, the residual error. As the time intervals were different, the 
following covariance structures were compared: SP(POW), SP(GAU), SP(EXP), SP(LIN), 
SP(LINL), SP(SPH), ANTE(1) and UN. For each variable, the statistical analysis retained was 
the one with the smallest fit statistic values. Results are reported as least squares means and 






differ at 0.05 < P ≤ 0.10, then the 2 following a priori comparisons were used: CC vs. CA + CW 
and CA vs. CW. 
Results and Discussion 
There was no effect of treatments (P ≥ 0.6) on milk production and DMI, averaging 33 ± 
2.5 kg/d and 19.6± 1.0kg/d, respectively. Arterial plasma concentrations of vitamin B12 increased 
when CN-CBL was infused with dairy proteins, from 323 pg/ml with CA to 408 pg/ml on 
average CC and CW (treatment effect, P=0.02; Table 2.2). Although portal plasma concentration 
of vitamin B12 was not changed by treatments (P=0.42, Table 2.2), concentration of vitamin B12 
varied over the time within treatments (interaction time × treatment, P<0.01, Table 2.1, in where 
CC and CW presented higher concentrations during the first hour after post-ruminal infusion 
compared with CA, and CC was higher than CA and CW 2 h after the post-ruminal infusion. On 
average porto-arterial differences of vitamin B12 were affected by the time after the post-ruminal 
infusion (time effect, P < 0.01; Table 2.2), being positive during the first 90 min after the 
abomasal bolus. The difference was maximal 30 min post-bolus and rapidly decreased, then from 
120 min after the abomasal bolus until the end of the sampling period, porto-arterial differences 
of vitamin B12 were negative or not different from 0 (data not shown). On average for the 24 h 
period following the post-ruminal bolus, there was a treatment effect (P < 0.05) for porto-arterial 
difference and net PDV flux of vitamin B12; CA and CW were negative whereas they were 
positive for CC (Table 2.2). On average the PDV net flux of vitamin B12 was positive during the 
first 45 min after the post-ruminal bolus, the maximal value was already reached 30 min after the 
bolus and decreased rapidly thereafter;  from 1 h until 24 h after the post-ruminal bolus, PDV net 
flux of vitamin B12 was negative (time effect, P < 0.01; Figure 2.2). Only 0.64% of the total 






0.74% at 45 min and then, there was no release until the end of the sampling period. In contrast 
with our findings the net flux of this vitamin across PDV in mid-lactation dairy cows was still 
positive 24 h after ingestion of a supplement of 500 mg CN-CBL (Girard et al., 2001). The post-
ruminal infusion dose in the present study was 5-fold less than the amount of CN-CBL used in 
the previous study (Girard et al., 2001) because Girard et al. (2009) observed that, in dairy cows, 
only 20 % of a dietary supplement of CN-CBL was recovered at the duodenal level. However, 
the results in the present study suggest that the dose infused post-ruminally might not be 
sufficient to reach similar net release of vitamin B12 across PDV-flux.  
In pigs, PDV flux of vitamin B12 was positive when dietary CN-CBL was given with a 
semi-purified diet containing vitamin-free casein (Matte et al., 2010). However, the PDV flux of 
vitamin B12 was negative or not different from 0 when CN-CBL was given in a meal based on 
corn, wheat and soybean meal (Matte et al., 2012). Indeed, in pigs intestinal absorption of 
vitamin B12 during the 24 h period after ingestion of milk was greater than after ingestion of the 
synthetic form of the vitamin (Matte et al., 2012). Little is known about the efficacy of milk 
protein as well as differences on the effect of casein vs. whey proteins on the intestinal 
absorption of CN-CBL. Milk proteins are natural vehicles of bioactives compounds (e.g. 
calcium, amino acids and inmunoglobulins) to the neonate (Livney, 2010). During digestion, 
milk proteins offer a variety of possibilities for reversible binding of active molecules and for 
protecting them until their release at the desired site within the body (Chen et al., 2006, Elzoghby 
et al., 2011). For instance, in non-ruminant animals, the rates at which peptides and AA are 
released during digestion differ among milk proteins (Boirie et al., 1997). Caseins form clots that 
slowly empty from the stomach, whereas whey proteins are rapidly digested resulting in high 






formulation for humans, called Cap-PEG-Insulin-Casein (CAPIC, BioSante Pharmaceuticals 
Inc., Baudette, MN), aggregates caseins around a proprietary formulation of insulin (Morçöl and 
Bell, 2001, Morçöl et al., 2004). Due to its mucoadhesive properties and its capacity to resist 
degradation under acidic conditions, casein protects the target drug as it passes through the 
stomach, allowing the drug to be released at the site of absorption (Park et al., 2011). Indeed, 
vitamin B12 has been used as a model drug incorporated into a casein hydrogel matrix which has 
an in vitro prolonged release behavior (Song et al. 2010). Thus, milk casein seems suitable as 
vehicle or as component for the construction of vehicles for delivering various bioactive 
molecules, especially those that require slow intestinal delivery, such as vitamin B12.  
In summary, our data show that post-ruminal infusion of CN-CBL given with casein 
increased vitamin B12 intestinal absorption as compared to CN-CBL given alone. For practical 
applications of our findings, development a rumen protected vitamin B12 with casein may 
improve CN-CBL absorption in dairy cows. 
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Table 2.1 Ingredient and chemical composition of the total mixed ration
1
 
Ingredient, % DM basis  Value 








Canola meal 21.9 
Beet pulp 2.0 
Mineral and vitamin supplement
4 
1.8 
Calcium Carbonate  0.3 
Urea 0.2 
Megalac® 1.7 
Nutrient composition  
  MS, % 50.0 
  CP, % of DM 15.1 
  RDP, % of CP 49.4 
  Soluble protein, % of CP 31.1 
  ADF, % of DM 18.9 
  NDF, % of DM 32.6 
  NEL, Mcal/d 1.59 
  Co, mg/kg of DM 0.40 
1
All cows were served daily 1 kg of long hay (85% DM) on a DM 
basis, 10.5% CP; 2.5% soluble protein; 30.6% ADF; 54.4% NDF 
2
8.6% CP; 3.4% soluble protein; 21.7% ADF; 40.0% NDF 
3
16.7% CP; 7.7% soluble protein; 31.2% ADF; 47.6% NDF 
4
Contained per kilogram: 91.8 g of Ca; 47.9 g of P; 47.9 g of Mg; 
11.9 g of K; 80.8 g of Cl; 136.8 g of Na; 15 g of S; 1,946 mg of Fe; 
2,656 mg of Zn; 440 mg of Cu; 1,798 mg of Mn; 23 mg of I; 19.50 
mg of Se; 441.6 kUI of vitamin A; 56.6 kUI of vitamin D and 2,630 












Table 2.2 Arterial and portal plasma concentrations, porto- arterial difference and net flux 
across portal-drained viscera (PDV) of vitamin B12 during the 24 h following a post-
ruminal bolus of cyanocobalamin alone (CA) or in solution with casein (CC) or whey 
protein isolate (CW) 
 Treatments  P values  P-value 
contrast 











































































Figure 2.1 Plasma concentrations of vitamin B12 in the portal vein of lactating dairy cows during 
the 24 h following a post-ruminal bolus of 100 mg of cyanocobalamin alone (CA) or in solution 
with casein (CC) or whey protein isolate (CW). Each symbol represents either CA (♦), CC () or 
CW (▲). alues are means from 4 cows per treatment, standard errors of the mean = 54.33 































































Figure 2.2 Net flux of vitamin B12 from the portal-drained viscera (PDV) of lactating dairy cows 
during the 24 h following a post-ruminal bolus of 100 mg of CN-CBL.  Values are means from 4 




















































CHAPTER 3: CHOLINE AND CHOLINE METABOLITE PATTERNS AND 







This chapter is a revised version of a paper by the same title in press on PlosOne by Virginia 
M. Artegoitia, Jesse L. Middleton, Federico M. Harte, Shawn R. Campagna, Michael J. de 
Veth. My primary contributions to this paper include (1) taking samples and preparation, (2) 
the collection and analysis of data, (3) the gathering and interpretation of literature, and (4) 
the manuscript writing 
 
Abstract 
Milk and dairy products are an important source of choline, a nutrient essential for human health. 
Infant formula derived from bovine milk contains a number of metabolic forms of choline, all 
contribute to the growth and development of the newborn.  At present, little is known about the 
factors that influence the concentrations of choline metabolites in milk. The objectives of this 
study were to characterize and then evaluate associations for choline and its metabolites in blood 
and milk through the first 37 weeks of lactation in the dairy cow. Milk and blood samples from 
twelve Holstein cows were collected in early, mid and late lactation and analyzed for 
acetylcholine, free choline, betaine, glycerophosphocholine, lysophosphatidylcholine, 
phosphatidylcholine, phosphocholine and sphingomyelin using hydrophilic interaction liquid 
chromatography-tandem mass spectrometry, and quantified using stable isotope-labeled internal 
standards. Total choline concentration in plasma, which was almost entirely phosphatidylcholine, 
increased 10-times from early to late lactation (1305 to 13,535 μmol/L). In milk, phosphocholine 
was the main metabolite in early lactation (492 μmol/L), which is a similar concentration to that 
found in human milk, however, phosphocholine concentration decreased exponentially through 
lactation to 43 μmol/L in late lactation. In contrast, phosphatidylcholine was the main metabolite 
in mid and late lactation (188 μmol/L and 659 μmol/L, respectively), with the increase through 
lactation positively correlated with phosphatidylcholine in plasma (R
2
 = 0.78). Unlike previously 
reported with human milk we found no correlation between plasma free choline concentration 






in milk through lactation observed in the bovine suggests that it is possible to manufacture infant 
formula that more closely matches these metabolites profile in human milk. 
Introduction 
Choline is found in various forms in humans and animals (Zeisel et al., 1991; Pinotti et al., 2002) 
(Figure 3.1).  The water-soluble choline metabolites include acetylcholine (ACho), an important 
neurotransmitter for brain and neuromuscular function (Zeisel et al., 1991), betaine (Bet), an 
oxidative intermediate of choline which supplies a methyl group for the conversion of 
homocysteine to methionine (Zeisel and Blusztajn, 1994), and glycerophosphocholine (GPCho), 
which like Bet acts as an organic osmolyte in cells (Gallazini and Burg, 2009). The lipid-soluble 
choline-containing metabolites phosphatidylcholine (PC), sphingomyelin (SM), and 
lysophosphatidylcholine (LPC) are all structural components of mammalian membranes (Zeisel 
1990).  PC is essential for synthesis of VLDL, a key mechanism to export triacylglycerol from 
the liver (Yao and Vance, 1988). 
Choline can be obtained from the diet (Zeisel et al., 2003) and from endogenous biosynthesis 
that predominantly occurs in the liver via the phosphatidylethanolamine N-methyltransferase 
(PEMT) pathway (Reo et al., 2002).  Although the PEMT pathway represents an important 
source of choline (Zeisel and Blusztajn, 1994), dietary intake of choline is necessary because the 
pathway supplies insufficient choline moiety to maintain the normal function of cells, tissues and 
organs (Zeisel et al., 2003; Reo et al., 2002).  In the case of the ruminant, however, dietary 
choline is extensively degraded (>80%) by rumen bacteria (Neill et al., 1979; Sharma and 
Erdman 1989) and therefore endogenous synthesis via the PEMT pathway represents a critical 
source of choline (Baldi and Pinotti, 2006).  For the lactating dairy cow, the periparturient period 






protected choline has been found to reduce the extent of hepatic fatty infiltration and increase 
expression of genes involved in VLDL transport (Zom et al., 2011; Goselink et al., 2012.  
Despite the lack of dietary-derived choline in the ruminant, milk and dairy products are an 
important source of choline in the human diet. One cup of retail milk (2% fat) is expected to 
provide approximately 40 mg choline (Howe et al., 2004), which represents nearly 10% of an 
adult woman’s daily choline requirement (Zeisel and da Costa, 2009). In addition, bovine milk is 
the main ingredient used in the manufacture of infant formula (IOM, 2004), which is used during 
a period of human development where choline requirements are high for organ growth and 
membrane biosynthesis (Caudill 2010).  Studies that have compared the choline content of breast 
milk and infant formula have found that whilst the total choline in breast milk was relatively 
constant [1250-1481 µmol/L), choline in bovine-derived infant formula varied by over 7-fold 
(311-2270 µmol/L) (Ilcol et al., 2005 Holmes-McNary 1996). Further, these studies have found 
the proportion of the various choline metabolites in milk differs for breast milk and infant 
formula, which may be important for the neonate as the bioavailability of the choline metabolites 
can vary considerably (Cheng et al., 1996).  Despite the variation in choline content and choline 
metabolite proportions of bovine-derived infant formula, it is not known to what extent this 
variation may be attributed to the milk initially harvested from cows or due to post-harvest 
processing.   
Lactation is characterized by extensive physiological adaptations that are coordinated to provide 
the appropriate quantity and pattern of nutrients for milk synthesis (Bauman and Currie, 1980).  
These adaptations have been associated with changes in choline metabolism, with differences in 
choline metabolite concentrations during lactation reported in breast milk and porcine milk (Ilcol 






changes in choline metabolites in plasma and milk during lactation in dairy cows. Recently, a 
method based on hydrophilic interaction liquid chromatography-tandem MS (HILIC LC-
MS/MS) was developed and validated to identify and quantify all of the major choline-
containing compounds as well as their  fatty acid composition within a phospholipid class (Zhao 
et al., 2011, Xiong et al., 2012).  
The objectives of the current study were threefold. Firstly, we sought to characterize the changes 
in choline and choline metabolites in blood and milk over the first 37 weeks of lactation (WOL) 
by sampling during early, mid and late lactation, which is indicative of periods in lactation where 
the physiological state differs greatly in the dairy cow.  The quantification of choline output in 
milk will contribute to an understanding of the mammary glands’ requirement for choline during 
lactation. In addition, changes in the different PC species were of interest as recent research has 
shown that PC species with long chain polyunsaturated fatty acids, primarily docosahexaenoic 
acid (DHA), originated from PEMT activity in the liver of rodents and humans (da Costa et al., 
2011, Pynn et al., 2011). Secondly, we sought to determine whether the yield of choline and 
choline metabolites in milk were associated with changes in blood choline metabolite 
concentrations. Previously, weak correlations between blood and milk choline concentrations 
were found in nursing women (Ilcol et al., 2005).  In the present study, we had the advantage of 
monitoring the same animals throughout lactation, which was expected to reduce the variation 
and improve the likelihood of observing interrelationships. Thirdly, we sought to determine the 
relationship between milk choline yield and common animal performance variables (i.e. milk 
yield, fat and protein content, and WOL) to evaluate whether easily measurable end points could 







Materials and Methods 
Animal experimentation was approved by The University of Tennessee Institutional Animal 
Care and Use Committee. 
Twelve multiparous Holstein cows averaging 653 ± 55 kg (mean ± SEM) body weight 
were recruited at calving and managed under the same diet, without choline supplementation, 
throughout the study. 
The diet was a total mixed ration (TMR) formulated using the National Research Council 
requirements (NRC, 2001) and were fed ad libitum at 0700 and 1900 daily (Table 3.1). Water 
was available at all times. TMR samples were collected once each month during the experiment 
and stored at −40°C before being analyzed for chemical composition by wet chemistry (Dairy 
One Cooperative, Inc., Ithaca, NY). The individual ingredients that comprised the TMR diet 
were analyzed for choline metabolites (Table 3.2). 
Milk and blood samples were collected on one day each week during three periods of the 
lactation, early lactation (weeks 1, 2 and 3; n=12), mid lactation (weeks 7, 10 and 13; n=12) and 
late lactation (weeks 31, 34 and 37; n=10). Cows were milked at 0600 and 1800 h daily. Milk 
was sampled and yield determined at both daily milkings (pm and am) of each week. One aliquot 
was stored at 4°C with a preservative (bronopol tablet; D&F Control System, San Ramon, CA) 
until analyzed for fat and true protein content (Tennessee DHIA, Inc., TN) by mid-infrared 
spectrophotometry (Milko-Scan, Foss Electric, Hillerød, Denmark). A second aliquot of milk 
was stored at −40°C for choline metabolite analysis.  lood samples were taken after the am 
milking from the coccygeal artery/vein with a Vacutainer-EDTA (Becton Dickinson Inc, 
Franklin Lakes, NJ), immediately placed on ice, centrifuged (2000g at 4 C° for 10 min) and 






The absolute quantification of choline and choline metabolites at each WOL was 
determined using isotope dilution MS with the exception of GPCho where an external calibration 
curve was used because no commercial internal standard (IS) was available. Stock solutions of 
the IS in methanol were prepared so that the final concentration in the autosampler vial was ca. 5 
times greater than the lower limit of linearity of the target compound to ensure an analyte to IS 
signal ratio greater than 10:1  to avoid suppressing the target compound signal (Zhao et al., 
2011). The following standards were used: Cho chloride-trimethyl-d9 (Cho-d9, Cambridge 
Isotope Laboratories  DLM 549-1, Tewksbury, MA), Bet (Bet-d11 Cambridge Isotope 
Laboratories DLM 407, Tewksbury, MA), PCho chloride (PCho-d9, Cambridge Isotope 
Laboratories, DLM-298, Tewksbury, MA) PC-d9 (Avanti polar lipids, 860362, Alabaster, AL), 
SM-d13-c13 (Ricerca-custom made, Painesville, OH) ACho-d13(C/D/N Isotopes ICN D-1780, 
Quebec, Ca), LPC-D3 (Larodan 71-2826, Malmo, Sweden). The ratio between the area of the 
target compound and area of the IS was multiplied by the known IS concentration to quantify the 
various phospholipids. A calibration curve was used to calculate the absolute quantitation of 
GPCho concentration (1-O-Octadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine, Sigma, 
09262). Serial dilutions were made from 0.0012 µl to 11857.55 µl concentration of GPCho in 10 
mL of methanol resulting in a linear equation using for quantification. 
Milk samples from consecutive milkings (pm, am) on each sampling day were 
composited proportional to milk yield at each milking prior to extraction for choline analysis. 
Plasma, milk and feed samples were extracted based on the Bligh and Dyer (1959) method with 
modifications described by Zhao et al. (2011). The samples were kept on ice throughout the 
extraction process. Briefly, 1 ml of extraction solvent (chloroform, methanol, water, 1:2:0.8) was 






solution. The samples were centrifuged at 28620g and 4°C for 5 min. The resultant supernatant 
was transferred into a separate glass vial. The extraction procedure was repeated twice and each 
time the supernatants were collected into the same vial. The combined extracts were dried under 
constant nitrogen steam and then re-dissolved in 5 ml of methanol. 
Metabolites of choline (Figure 1) were analyzed using HILIC LC-MS/MS based on 
methods outlined by Zhao et al. (2011). A Finnigan Surveyor MS Pump Plus coupled to a 
Finnigan Surveyor Autosampler was used to introduce the samples onto an Ascentis Express 
HILIC column (150  2.1 mm, 2.7 µm particles) HPLC separation. The autosampler tray 
temperature was 4°C and full loop injections of 10 µL were used.  The column temperature was 
set at 25°C and 200 µL/min flow rate was used.  The mobile phases were acetonitrile (ACN, 
solvent A) and 10mM ammonium formate in water buffered to pH 3.0 with formic acid (solvent 
B).  A 30 min gradient was performed: t) 0.1 min, 8% solvent B; t) 10 min, 30% solvent B; t) 15 
min, 70% solvent B; t) 18 min, 70% solvent B; t) 18.01 min, 8% solvent B; t) 30 min, 8% 
solvent B.  At the end of analysis the column was flushed with 100% ACN for 30 min prior to 
storage to preserve the stationary phase and to prevent retention time shifts in subsequent 
analyses. 
Fused silica tubing (0.10 ID 0.19 mm OD) was connected to the ion source housing of a 
Finnigan TSQ Quantum Discovery MAX operating in electrospray ionization (ESI) mode for 
sample introduction. Ion source parameters were 4500 ESI spray voltage and 290°C ion transfer 
capillary temperature. Nitrogen was used as a sheath gas set at 40 arbitrary units at the 
instrument and 100 psi from the source.  Argon collision gas was set to 1.5 mTorr in the collision 
cell and 20 psi from the source.  The selected reaction monitoring (SRM) transitions were used 






width at half maximum of 0.7 Da.  Parent and product masses were rounded to 0.1 m/z unit. A 
complete list of masses and collision energies used were reported by Zhao et al. (2011). SRM 
transitions of internal standards were: PC 799.7 to 193, SM 735.6 to 188, AC 159.4 to 91.2, LPC 
499.3 to 184, Cho 113.2 to 69.1, Bet 129.1 to 66.2, and PCho 193 to 125.1.  Two segments were 
used to lower duty cycle.  Segment 1 was from 0-10.8 min, and contained the SRM transitions 
for all PC and SM.  Segment 2 was from 10.8-30 min, and contained the SRM transitions for 
SM, AC, LPC, Cho, Bet, GPCho, and PCho. All Finnigan instruments were operated using 
Xcalibur (Thermo Fisher Scientific Inc., Waltham, MA, version 2.0.7) installed on a Dell 
Precision 390 computer. The data was processed with the Xcalibur 2.0.7 Quan Browser software 
(Thermo Fisher Scientific Inc., Waltham, MA). 
Effects of WOL on milk composition and milk and plasma choline metabolites were 
analyzed using the GLIMMIX procedure of SAS (SAS version 9.3 Institute Inc., Cary, NC, 
USA). The model included WOL as fixed effect, cow as a random effect, with WOL as the 
repeated measure, and spatial power as the covariance structure because of unequal sampling 
intervals. Means are reported as least squares means with their respective pooled standard errors 
and considered to differ when P ≤ 0.05. For choline metabolites that had unequal variance the 
data was Log10 transformed. 
Hepatic and mammary PEMT activity was evaluated from the PEMT ratio which was 
calculated based on the ratio of PC species containing DHA to total PC in blood and milk, 
respectively (da Costa et al., 2011; DeLong et al., 1999). While in two instances there was 
coelution of PC containing DHA with other long-chain polyunsaturated fatty acids, DeLong et 
al. (1999) reported the same coelution of PC species associated with PEMT activity.  






explored. When effects were found significant, polynomial (PROC GLIMMIX) and exponential 
(PROC NLIN) relationships were evaluated. Model adequacy was assessed based on mean 
square error, residuals against both fitted and predicted values, and normal probability plot.  In 
addition, relationships between choline metabolites in milk and blood were examined. Variable 
selection was performed and relationships between selected variables were evaluated using 
PROC REG.  Finally, multiple regression analysis was conducted using PROC REG to assess the 
relationship between milk total choline yield and animal performance variables (i.e. milk yield 
and milk composition) during lactation. 
Results 
Animals were sampled on each of three days during early, mid and late stages of 
lactation; their yield and composition of milk is shown in Table 3.3. As expected, milk yield 
followed the typical lactation curve, increasing from early to mid-lactation and then decreasing 
during late lactation. Milk protein yield did not change during lactation; however, milk fat yield 
was higher in early lactation and then decreased as lactation progressed. Milk fat and protein 
concentration were greater at the start of lactation, lowest at mid and intermediate at the end of 
lactation. 
The main choline metabolites detected in plasma were PC, SM and LPC, with the 
concentration of all metabolites changing over lactation (Table 3.4). PC was the predominant 
choline metabolite found in plasma, with its proportion of total choline increasing from 77% at 
the onset of lactation to 95% by late lactation. Also PCho and Bet concentrations in plasma were 
the highest at the end of the lactation. In contrast, SM and LPC concentrations in plasma 
increased from early to mid-lactation and then decreased in late lactation. ACho was not detected 






degraded. The concentration of total choline in plasma showed a positive quadratic relationship 
with WOL (Figure 3.2), increasing up to 10-times from early to late of lactation, which was 
mainly explained by the increase in PC.  The profile of fatty acids bound to LPC, containing a 
single fatty acid, and PC, containing a combination of two fatty acids, were quantified in plasma 
and milk during lactation.  The plasma concentration of all forms of LPC and PC changed during 
lactation (Table 3.5). The main fatty acid associated with LPC in plasma was linoleic acid 
(C18:2) and all forms, except LPC containing stearic acid (C18:0), increased from early to mid-
lactation and then decreased in late lactation. For PC, the concentrations of all species increased 
in plasma from early to late lactation regardless of fatty acyl composition. 
The concentration and yield of all choline and choline metabolites in milk, except for 
LPC yield, changed during lactation (Table 3.6). The two main choline metabolites in milk were 
PC and PCho, which together represented 60 to 80% of the total choline in the milk. The yield of 
PtdCho increased linearly through lactation, from <5 g/d in early lactation to >12 g/d by late 
lactation (Figure 3.3A). In contrast PCho was the main choline metabolite in early lactation 
(averaged 2.7 g/d), and its yield displayed an exponential decay as lactation progressed (Figure 
3.3B).  
The total output of choline in milk (based on the moiety alone) was lowest in mid 
lactation, averaging 1.8 g/d, whereas it averaged 2.7 g/d and 3.1 g/d in early and late lactation, 
respectively (Table 3.6). The yield of free choline in milk increased during the initial 3 weeks of 
lactation and then remained constant until the end of lactation (Table 3.6). In milk, except for 
18:0/22:5 PC, the concentrations of all double fatty acid pairings within PC increased from early 
to late lactation (Table 3.7).  The main fatty acids found in LPC were palmitic acid whereas 






When evaluating relationships between the choline metabolites in plasma and milk we 
found that milk PC yield increased linearly as PC concentration in plasma increased (Figure 4A). 
In contrast, milk PCho yield showed a negative exponential decay with increased PC 
concentration in plasma (Figure 4B). We also evaluated the relationship between WOL and the 
PEMT ratio in plasma and milk. There was no consistent pattern in the plasma PEMT ratio over 
lactation, whereas in milk the ratio was highest during early lactation  
Finally, the multiple regression analysis found that WOL, milk yield and the content of 
fat and protein in milk, were able to explain a moderate proportion of the variation in total 
choline in milk during lactation (R
2
=0.67; p<0.001). The model obtained for total choline yield 
in milk (γ; g/d) was 
yieldproteinfatWOLWOL 351.004.2492.0015.0221.06.11 2   
Where WOL is week of lactation, fat is percentage of fat in milk, protein is the 
percentage of protein in milk, and yield is daily milk yield (kg); SEE were 4.88, 0.166, 0.004, 
1.24, 0.377, 0.048, respectively. 
 
Discussion 
Milk and dairy products derived from the bovine are a rich source of choline for the human diet; 
however; little is known about how choline varies in milk during lactation in the dairy cow.  In 
addition, choline is found in various water- and lipid-soluble forms in milk, which can differ in 
their absorption, transport and metabolism in the nursing infant (Davenport and Caudill, 2013). 
When comparing the concentration of serum choline metabolites in infants fed either breast milk 
or bovine-based infant formula, Ilcol et al. (2005) reported around 2-fold greater serum Cho 






water-soluble choline metabolites (i.e. Cho, PCho and GPCho) in breast milk.  Therefore, 
characterizing the changes in choline metabolites in bovine milk during the course of lactation 
may form the basis to enhance the choline metabolite profile in bovine-derived infant formula.  
We adopted methodology that has been recently developed and validated to detect the major 
choline metabolites in egg yolk (Zhao et al., 2011; Xiong et al., 2012). This technique utilizes 
HILIC LC-MS/MS that, as well as providing improved sensitivity, has an advantage over other 
analytical methods as it identifies all the major choline metabolites (Figure 3.1) and differentiates 
the fatty acid chains in PC and LPC in a single chromatographic run.  We also used matching IS 
for each analyte class, except GPCho, for absolute quantification for a member of each choline 
metabolite class as well as for enhanced quantification of all other compounds. 
Choline and choline metabolites in blood were of interest as it is unknown how their 
concentrations may change during lactation in the dairy cow. When comparing free choline 
concentration in plasma, dairy cows in our study had 3- to 4-fold lower levels than previously 
reported for breastfeeding woman (Ilcol et al., 2005). In ruminants dietary choline is extensively 
degraded in the rumen (Sharma and Erdman, 1989; Baldi and Pinotti, 2006), which may explain 
the low and constant levels of free choline in plasma during lactation in the present study. We 
did find an increase of over 10-times in the total choline concentration in plasma from early to 
late lactation, with the majority of the increase coming from elevated PC levels. The plasma PC 
concentrations in early lactation were similar to that previously reported in breast feeding women 
(Ilcol et al., 2005); however, levels in blood were much higher at mid and late lactation in our 
study. PC is the main phospholipid component in all the lipoprotein classes, with its proportion 
ranging from 60 to 80% of total phospholipids (Cole et al., 2012). As lactation progresses there 






cows (Raphael et al., 1973). Therefore, the increased concentrations of PC are expected to have 
been associated with the changes in types and levels of lipoproteins in plasma that occur during 
lactation. 
The levels of the choline moiety in milk during lactation were important to consider as 
milk from the bovine is an important source of choline for the human diet.  The USDA database 
for choline content in foods indicates that retail milk with 2% fat has 16 mg/100 g (Howe et al., 
2004).  In the present study the total choline moiety concentration in milk was lower than that 
reported by USDA throughout lactation; with mid lactation levels less than half of late lactation 
levels (averaged 8.3, 5.0 and 11.1 mg/100 g in early, mid and late lactation, respectively).  
Similar choline moiety levels in milk of dairy cows, when not supplemented with choline, have 
previously been reported by Deuchler et al. (1998) across 3 experiments (ranged from 6.6 to 8.9 
mg/100 g) and by Pinotti et al. (2003) (10.0 mg/100 g).  The basis for the difference between 
these animal studies which have analyzed choline in milk collected at harvest and the USDA 
database is not clear, although it may relate to milk processing and/or the low number of retail 
samples (n=2) used to develop the USDA database estimate.  Considering this large difference in 
choline levels in milk and the importance of choline originating from dairy to the human 
population, further evaluation of choline levels in milk may be warranted to ensure choline 
intake meets requirements. 
Although choline is considered an essential nutrient and dietary requirements have been 
developed for almost all domestic animal species, presently there is no requirement established 
for lactating dairy cows by the NRC (2001).  Nutrient requirements for lactating dairy cows are 
partitioned by the NRC based on their use for maintenance, pregnancy, growth and lactation.  






understanding of the incorporation of choline in milk and how this varies through lactation. This 
approach has been used in the past for humans, where the dietary reference intake for choline is 
30% higher (125 mg/d) for breastfeeding women than it is for non-breastfeeding woman, with 
the higher level of intake calculated based on predicted levels of choline secreted daily in milk 
(Pitkin et al., 2000). In the current study, the yield of the choline moiety increased over 2-fold 
from mid to late lactation (1.6 vs 3.5 g/d, respectively). Previously Deuchler et al. (1998) 
reported choline levels in milk of cows, also when not supplemented choline, in early lactation 
(2.6 g/d) and mid-lactation (2.1 g/d) that is within the range observed in our study. Although 
these dairy cattle studies may give an indication of the choline requirement for lactation, research 
is needed to better understand what levels of choline are needed for non-lactating functions.  This 
is particularly important in the case of the peripaturient dairy cow where there is a high 
prevalence of fatty liver disease (Zom et al., 2011), which is the classic symptom of choline 
deficiency (Garrow, 2007). 
Changes in choline and its metabolites during lactation have previously been reported in 
human and porcine milk (Ilcol et al., 2005; Donovan et al., 1997); however, there has not been a 
systematic evaluation of changes during lactation in choline metabolites in milk of dairy cows. 
Recently Klein et al. (2011) used NMR to provide relative quantification to estimate the range in 
concentration of four water-soluble choline metabolites in milk during lactation of dairy cows.  
For Cho, Bet and GPCho, the lowest level of the range (10% quantile) reported by Klein et al. 
(2011) were all greater throughout lactation than the average concentrations measured in our 
study, however, the changes in these 3 choline forms and PCho through lactation were all similar 
across the two studies.  When comparing the concentration of all eight choline metabolites we 






choline forms), whereas PC was the main choline metabolite after early lactation and increased, 
as a percentage of total choline forms, from 36% at week 7 to 71% at week 37 of lactation.  The 
PC concentration in cow’s milk in late lactation (ranging from 582 to 701 μmol/L) was much 
greater than that previously reported by Ilcol et al. (2005) in human milk at any point in lactation 
(ranging from 97 to 155 μmol/L).  In contrast, the concentration of  M in cow’s milk (38 
μmol/L) was lower than found in human milk (92 μmol/L) when compared across lactation (Ilcol 
et al., 2005). In the present study, PCho was the main water soluble choline metabolite in cow’s 
milk, which is similar that reported for porcine milk (Donovan et al., 1997) and human milk 
(Ilcol et al., 2005).  In contrast to our study, Ilcol et al. (2005) found no relationship between the 
concentration of PCho in breast milk and day after birth, although their study was cross-sectional 
and did not sample individuals over time.  Early research comparing the choline metabolites in 
breast milk and infant formula suggested that infant formula had lower levels of PCho than 
breast milk (Holmes-McMary et al., 1996; Holmes et al., 2000); however, recent data from Ilcol 
(2005) and the present study results indicate that there is a large range in PCho in both breast 
milk (100 to 1200 µmol/L) and unprocessed bovine milk (12 to 820 µmol/L).  This suggests that, 
if an ideal PCho level can be determined for infant nutrition, milk from dairy cows in specific 
stages of lactation might be used to manufacture infant formula to better match breast milk 
concentrations of PCho. 
The levels of the choline metabolites in milk are of interest as it has been shown that the 
absorption and bioavailability can differ across the various metabolites.  Cheng et al. (1996) 
reported that when radiolabeled choline forms were added to infant formula fed to suckling rat 
pups, Cho and PCho rapidly appeared in blood and the liver, whereas PC took longer to appear 






choline and PCho versus PC in blood were likely due to independent mechanisms of absorption 
at the small intestine (Cheng et al., 1996).  PC is hydrolyzed by phospholipase A2 in the intestine 
and the LPC that is generated is absorbed by passive diffusion.  However, PCho is hydrolyzed by 
phosphatase to free choline, which is absorbed via carrier-mediated transport at the intestine 
(Garrow, 2007). In addition, in the calf after birth intestinal phosphatase activity is high (Le 
Huerou et al., 1992) whereas phospholipase A2 enzyme activity is low at birth and increases 
after weaning (Huerou-Luron et al., 1992).  Therefore, the functional importance of higher milk 
PCho in early lactation, observed in similar concentrations (~500 μmol/L) in the human, porcine 
and bovine, may be to provide a rapidly bioavailable supply of choline for sustaining growth and 
maintenance of new born animals.  
There is little known about the uptake of choline and its metabolites from circulation by 
the mammary gland.  In the human free choline can be taken up from circulation (via active 
transport) by the mammary epithelium across a steep concentration gradient (Davenport and 
Caudill, 2013; Chao et al., 1988), and recently Ilcol (2005) found a positive correlation between 
serum free choline and milk free choline concentrations (r=0.74, p<0.01).  In the current study, 
we found a positive linear relationship between PC concentration in plasma and PC yield in milk 
of dairy cows (r=0.55, p<0.01; Figure 4A).  However, unlike the trends observed in humans, we 
did not find an association between plasma free choline and choline in milk, which may relate to 
the low concentration of free choline in blood of the dairy cows throughout lactation (<4.5 
µmol/L) compared to that reported in breast-feeding woman (>14.6 µmol/L). 
PC can be synthesized in the body through phosphorylation of choline from the diet or via 
endogenous synthesis mediated by PEMT in the liver (Reo et al., 2002) and mammary gland 






acids, with PEMT the main origin of long-chain polyunsaturated fatty acids, primarily DHA, in 
rodent and human hepatocytes (DeLong et al., 1999; Pynn et al., 2011). In addition, a recent 
study in humans (da Costa et al., 2011) found that the ratio of DHA to total fatty acids in plasma 
PC was a useful marker for in vivo hepatic PEMT activity. Although we were not able to 
quantify total DHA in PC, due to coelution of some of the PC molecular species, the detection of 
DHA occurred in combination with other long-chain polyunsaturated fatty acids (arachidonic 
acid and docosapentaenoic acid) that originate primarily from the PEMT pathway (DeLong et 
al., 1999; Pynn et al., 2011). We did not find a consistent pattern in the PEMT ratio in plasma 
across lactation, but a reduction in the ratio in milk from 0.009 to 0.004 was observed from early 
lactation to late lactation.  Although the PEMT ratio has not been used to predict PEMT activity 
in the mammary gland, our results may suggest that mammary endogenous biosynthesis of 
choline dropped from early to late lactation and this was consistent with increasing plasma PC 
concentrations as lactation progressed.  Interestingly, the plasma PEMT ratio in the current study 
was several-times lower than that reported by da Costa et al. (2011) and Pynn et al. (2011) in 
plasma of humans and mice, suggesting PC derived from hepatic PEMT activity may contribute 
a smaller proportion of total PC in the cow.  This aligns with earlier results reported for 
ruminants by Robinson et al. (1984) where they found hepatic PEMT in vitro activity from sheep 
tissues was around one-quarter of that measured in the rat.  In addition, unlike rodents and 
humans, where almost all PEMT activity occurs at the liver (Reo et al.,2002) Robinson et al 
(1987) reported that the majority of choline derived from PEMT activity came from extrahepatic 
tissue in sheep, with skeletal muscle contributing around 60% of this activity. 
Multiple regression analysis indicated that milk production variables (i.e., fat and protein 






secreted in milk.  This result suggests that choline metabolites in milk, in addition to being 
located in the bilayer membrane of the fat globule (Lopez et al., 2008), may also be related to the 
protein component in milk.  As a greater understanding of the requirement for choline is 
developed for the lactating dairy cow there may be value in predicting milk choline output based 
on easily measurable variables on farm. The association we found in this study, although 
developed based on a small sample set of cows, suggest that the prediction of milk choline 
output may be possible with typically measured animal and production variables. 
In conclusion, the present study quantifies the eight major choline metabolites in blood 
and milk during lactation in the dairy cow. Total choline in plasma increased over 10-times from 
early to late lactation, with the majority of the increase coming from elevated PC levels.  The 
concentration of the choline moiety in milk decreased from early to mid-lactation before rising 
again in late lactation; however, throughout lactation milk choline remained below the levels 
reported previously in commercial milk. In milk PCho was the main metabolite in early lactation 
and decreased rapidly over the first weeks of lactation. The high PCho levels in early lactation 
have also been seen in the human and porcine and may be of importance in ensuring a rapidly 
bioavailable form of choline for the nursing young.  In contrast, PC in milk was lowest in early 
lactation and increased steadily through lactation, with this change positively correlated with PC 
in plasma.  Finally, we found that production variables (milk yield and milk fat and protein 
content) along with WOL were correlated with total milk choline yield, suggesting that it may be 
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Dietary dry matter averaged 840 g/kg. 
2 
Contained per kilogram: ground corn 197 g, cottonseed 200 g, wheat 
 mids 95 g, corn gluten feed 85 g, cottonseed hulls 75 g, citrus  
pulp 70 g, soybean meal 65 g, cottonseed meal 60 g, distillers grain 
 with soluble 46 g, calcium salts of palm fatty acids 20 g, fish meal  
20 g, cane molasses 20 g, ground limestone 20 g, sodium  
bicarbonate 10 g, urea 7 g, salt 5 g, Zn methionine 5 g. vitamin A 
 12665 IU, vitamin D 2760 IU, vitamin E 90 IU, selenium 0.3 mg,  
copper 12.9 mg, Zinc 50 mg, cobalt 0.23 mg, manganese 49 mg,  
iron 80 mg, iodine 0.50 mg. 
3
Analysis by Dairy One Inc., Ithaca, New York. 
4
 Net energy for lactation 
  
Ingredient (g/kg dry matter)
1
  





Clover hay 22 
Rye grass hay 28 
Alfalfa hay  18 
Chemical analysis (g/kg dry matter)
3 
 
Crude protein  181 
Neutral detergent fiber 452 
Acid detergent fiber 312 
NEL
4






Table 3.2 Choline and choline metabolite concentration in individual feed ingredients used 
to make the total mixed ration. 
 
1
Acetylcholine (ACho), betaine (Bet), free choline (Cho), glycerophosphocholine (GPCho),   
lysophophatidylcholine (LPC), not detected (nd), phosphatidylcholine (PC), phosphocholine  
(PCho), sphingomyelin (SM), total choline (TC). 
2
TC is the sum of ACho, Cho, LPC, PC, PCho, SM and GPCho. 
3
See Table 1 for ingredient composition of the supplement mix. 
  
Ingredient Choline and choline metabolite
1
, mg/100 g  
 ACho Bet Cho LPC PC PCho SM GPCho TC
2
 





0.12 65.2 23.1 27.6 974.7 0.75 0.39 40.02 1132.0 
Corn nd 5.0 9.8 4.0 30.9 0.08 nd 3.18 47.9 
Clover hay 0.02 10.7 39.0 3.7 74.2 0.68 0.06 5.19 122.9 
Rye grass hay 0.02 8.4 33.3 0.6 11.8 0.14 0.02 0.91 46.8 


















 Means within a row with different superscripts differ (P < 0.05).  
  
 Week of lactation 







































































































Table 3.4  Choline and choline metabolites concentration in plasma (μmol/L) of dairy cows during lactation. 
1
Betaine (Bet), free choline (Cho), glycerophosphocholine (GPCho), lysophosphatidylcholine (LPC), phosphatidylcholine (PC),  
phosphocholine (PCho), sphingomyelin (SM), total choline (TC). 
2
Variables were Log10 transformed to obtain equal variance. Means and SEM are back-transformed. 
3
TC is the sum of Cho, LPC, PC, PCho, SM and GPCho. 
abcd






Stage and week of lactation 
Early Mid Late 






















































































































































Table 3.5 Concentration of lysophophatidylcholine (LPC) and phosphatidylcholine (PC) with a particular fatty acyl chain in 
plasma of dairy cows during lactation. 
 
1
All metabolites, except for LPC 18:1 were Log10 transformed to obtain equal variance. Means and SEM represents  
non-transformed data. 
2
Two or three possible combinations of fatty acids were identified by the same product ions from HILIC LC-MS/MS. 
 
Stage and week of lactation 
Early Mid Late 
1 2 3 SEM 7 10 13 SEM 31 34 37 SEM 
Metabolite concentration1, μmol/L 
LPC             
16:0 18.9e 22.7de 30.7c 2.97 52.4a 41.1ab 50.7a 5.07 33.2bc 28.9cd 28.0cd 3.51 
18:0 18.1d 23.7d 34.4c 4.01 64.5ab 53.5b 73.2a 8.53 65.2ab 59.1ab 54.1ab 8.29 
18:1 24.7d 27.9d 39.6cd 5.87 62.5a 50.3abc 59.0ab 5.87 48.4abc 41.7bcd 38.6cd 6.46 
18:2 40.2f 56.0e 77.2d 9.6 161.9a 125.7ab 165.3a 20.5 113.7bc 99.4bcd 86.6cd 15.4 
PC             
16:0/16:0 8d 12c 13c 1.5 53b 52b 65b 7.5 166a 140a 127a 20.7 
16:0/16:1 8d 10c 12c 1.4 44b 42b 52b 6.1 132a 114a 105b 16.7 
16:0/18:1 142d 183c 210c 19.7 497b 476c 534b 50.2 970a 901a 851a 97.8 
16:0/18:2 265f 371e 457d 42 1423c 1431d 1694c 156 3160a 2896ab 2413b 315 
16:0/20:3 86f 119e 148d 14 435c 459c 577b 53 1046a 1009a 844a 104 
16:0/20:4 34e 50d 64c 6.4 204b 203b 253b 25.3 497a 445a 394a 53.7 
16:0/20:5,16:1/20:42 7e 9d 11e 1.3 40b 38b 50b 5.6 120a 111a 102a 14.7 
16:0/22:6,18:1/20:5,              
18:2/20:42 6.8e 9.3d 10.7d 1.1 36.1c 33.4c 41.8c 4.4 94.6a 74.0ab 65.0b 10.9 
18:0/18:1 107d 153c 184c 18.2 501b 493b 594b 58.8 1145a 1073a 934a 98.9 
18:0/18:2,18:1/18:12 243g 356f 446e 42 1394d 1479d 1856c 176 3385a 3269ab 2633b 346 
18:0/20:3 24f 41e 58d 8 286bc 271c 340b 52 1085a 1050a 974a 156 
18:0/20:4 35e 54d 67d 8 305bc 262c 369b 46 948a 866a 825a 128 
18:0/22:5 12e 19d 22d 2.7 90bc 72c 99b 12.5 246a 209a 203a 33.8 
18:1/20:4,18:0/20:5,             
16:0/22:52 22e 31d 36d 4.1 125bc 109c 147c 16.7 348a 293a 269b 42.9 
18:1/22:6 0.9f 1.5e 1.7e 0.20 6.6cd 6.0d 8.5c 1.02 19.6a 14.2ab 12.0b 2.56 
18:0/22:6,18:1/22:52 6f 9e 10e 1.2 42cd 35d 49c 5.9 121a 87ab 71b 16.0 







Phosphatidylethanolamine N-methyltransferase (PEMT) ratio = (16:0/22:6,18:1/20:5,18:2/20:4 + 18:1/22:6 + 18:0/22:6,18:1/22:5 )/ 
(16:0/16:1 + 16:0/20:5, 16:1/20:4 + 16:0/16:0 + 16:0/18:2 + 16:0/18:1 + 16:0/20:4  + 18:0/20:4 + 18:0/20:3 + 18:0/22:5 + 18:0/18:2, 
18:1/18:1 + 18:0/18:1+ 18:1/20:4,18:0/20:5,16:0/22:5) 
abcdef
















































Acetylcholine (ACho), betaine (Bet), free choline (Cho), glycerophosphocholine (GPCho), lysophophatidylcholine (LPC),  
not detected (nd), phosphatidylcholine (PC), phosphocholine (PCho), sphingomyelin (SM), total choline (TC),  
total choline moiety (TCM). 
2
Variables were Log10 transformed to obtain equal variance. Means and SEM are back-transformed. 
3
TC is the sum of ACho, Cho, LPC, PC, PCho, SM and GPCho. 
4
TCM is the sum of choline moiety originating from ACho, Cho, LPC, PC, PCho, SM and GPCho. 
 Stage and week of lactation 
Early Mid Late 

























































































































































































































































































































































































































Table 3.7 Concentration of lysophophatidylcholine (LPC) and phosphatidylcholine (PC) with a particular fatty acyl chain in 




Stage and week of lactation 
Early Mid Late 












































18:2 0.27 0.37 0.44 0.09 0.36 0.22 0.23 0.08 0.34 0.28 0.43 0.10 




































































































































































































































































   
 



























































































All variables, except for LPC 18:0 and phosphatidylethanolamine N-methyltransferase (PEMT) ratio, were Log10  
transformed to obtain equal variance.  Means and SEM represents non-transformed data. 
2
Two or three possible combination of fatty acids were identified by the same product ions from HILIC LC-MS/MS 
3
PEMT ratio= (16:0/22:6,18:1/20:5,18:2/20:4 + 18:1/22:6 + 18:0/22:6,18:1/22:5 )/ (16:0/16:1 + 16:0/20:5, 16:1/20:4  
+ 16:0/16:0 + 16:0/18:2 + 16:0/18:1 + 16:0/20:4  + 18:0/20:4 + 18:0/20:3 + 18:0/22:5 + 18:0/18:2, 18:1/18:1  
+ 18:0/18:1+ 18:1/20:4,18:0/20:5,16:0/22:5) 
abcde










Figure 3.1 Metabolism of choline and its metabolites. The compounds shown in boxes were 
assayed in milk and plasma in the current study. Phosphocholine and phosphatidylcholine are 
formed from choline via the cytidine diphosphate (CDP) choline pathway. The formation of 
betaine from choline is irreversible. Betaine when oxidized will provide a methyl group to 
homocysteine to form methionine. Methionine is converted to S-adenosylmethionine, which is 
an important methyl donor. Phosphatidylcholine can be formed endogenously by methylating 
phosphatidylethanolamine in a three step process involving S-adenosylmethionine via the 








Figure 3.2 Relationship between total choline concentration in plasma and week of lactation. The 





































Week of lactation 
y = 218 + 858x -13.7x2 
R2 = 0.75 









Figure 3.3 Relationship between week of lactation and milk yields of phosphatidylcholine (A), 
phosphocholine (B). The standard errors for the intercept and linear terms in (A) were 0.46 and 
0.02, respectively. The equation was y = a + b exp-cx with the standards errors for the fitted 
parameters in (B) were 0.106, 0.190, and 0.022 for a, b and c, respectively. 
 
y =  2.90 + 0.33x 
R² = 0.66 

























































Week of lactation 
y = 0.20 + 3.41exp-0.16x 
           R2 = 0.79 







Figure 3.4 Relationship between plasma phosphatidylcholine concentration and either yield of 
phosphatidylcholine (A) or phosphocholine (B). Each symbol represents either early (♦), mid 
() and late (▲) lactation. The standards errors for the intercept and linear terms in (A) were 
0.58 and 0.00007. The equation was y = a + b exp
-cx
 with the standard errors for the fitted 








































Plasma Phosphatidylcholine (μmol/L) 
Early Mid Late
y = 0.17 + 3.89exp-
0.0003x 
R2 = 0.78 
P-value ≤ 0.01 
 
y = 2.65 + 0.0007x  
R2 = 0.55 









































CHAPTER 4: EFFECT OF POST-RUMINAL INFUSION AND RUMEN-PROTECTED 
DELIVERY OF CHOLINE ON BLOOD AND MILK CHOLINE METABOLITES IN 






This chapter is a lightly revised manuscript by Artegoitia V. M., Girard C. L.; Lapierre H.; 
Campagna S. R., Harte F., de Veth M. J. The use of “our” in this chapter refers to my co-
authors and I. My primary contributions to this paper include (1) the sample preparation, (2) 
the collection and analysis of data, (3) the gathering and interpretation of literature, and (4) 
the manuscript writing. 
 
Abstract 
The majority of choline in feed ingredients is degraded in the rumen (NRC, 2001). Thus, rumen 
protected (RP) products have been developed to supply choline to the small intestine. However, 
the amount of choline absorbed at the small intestine (i.e. bioavailability) and its metabolism 
remain unknown. The objective of this study was to measure the effect of post-ruminal infusion 
and rumen protected choline (RPC) delivery of choline across the artery and portal and hepatic 
veins as well as in milk choline metabolites. Five lactating Holstein cows (206 ± 25 DIM) were 
used in a 5x5 Latin square design, with 5-d treatment periods and a 2-d interval between periods. 
Treatments were 1) control (0 g/d choline), 2) RPC - low dose (RPC-L), 3) RPC - high dose 
(RPC-H), 4) post-ruminal infusion (ABO) – low dose (ABO-L), 5) ABO - high dose (ABO-H). 
The low and high doses of RPC (Reashure, Balchem Corporation) and ABO each supplied 12.5 
and 25 g choline/d, respectively. On the last day of each period, milk samples were taken and 9 
blood samples were collected simultaneously from an artery, portal and hepatic veins at 30-min 
intervals Plasma, milk and feed ingredients were analyzed for acetylcholine (ACho), betaine 
(Bet), free choline (Cho), glycerophosphocholine, lysophosphatidylcholine (LPC), 
phosphatidylcholine (PC), phosphocholine (PCho) and sphingomyelin (SM) by hydrophilic 
interaction liquid chromatography-tandem mass spectrometry (HILIC LC-MS/MS). The plasma 
concentrations of total choline and lipid soluble choline metabolites (LPC, PC and SM) were not 






of the water soluble choline metabolites, Cho, Bet and PCho, were increased with ABO-L and 
ABO-H while PCho also increased RPC-H. The difference for Cho arterial concentrations 
increased almost 3 times with ABO-H compared to the control (P<0.01), while ABO-L or RPC 
treatments were not changed. There was a low level of total choline transferred into milk, 2.36% 
RPC-H and 5.12% ABO-H. For the increases in total choline moiety in milk, Cho and PCho 
represented 40% and 5%, respectively, for RPC-H and 60% and 24%, respectively for ABO-H. 
A multiple regression analysis indicated that yields of Bet and PCho in milk were associated 
(R
2
=0.76; P<0.01) with the total amount of choline post-ruminal infused. The association we 
found in this study, although developed based on a small sample set of cows at the end of the 
lactation, suggest that the prediction of choline supply may be possible based on Bet and PCho 
yields in milk.  
Keywords: Choline, bioavailability, dairy cow 
 
Introduction 
Choline is an essential nutrient routinely supplemented in monogastric (poultry and 
swine) to support growth, feed efficiency and reproduction (Sewell et al., 1966; Emmert et al. 
1997); however there is no choline requirement established for dairy cows. Choline has two 
known functions: as choline per se, when the choline moiety is required, and as a methyl donor 
(Pinotti, 2002). Choline moiety is a constituent cell membrane as phospholipids, 
phosphatidylcholine (PC), lysophosphatidylcholine (LPC) and sphingomyelin (SM). Particularly, 
PC is essential for the synthesis of VLDL which plays a major role in lipid transport and 






from the oxidation to betaine, which supplies a methyl group for the synthesis of methionine 
(Pinotti et al., 2002)  
Ruminants differ from monogastric as the majority of choline in feed ingredients and 
supplements like choline chloride are degraded in the rumen (NRC, 2001), therefore dietary 
choline make almost no contribution to the choline body pool.  In the dairy cow, despite low 
choline dietary availability, the output of choline compounds in milk are high and precursors 
from the de novo pathway may be limiting, especially at the onset of lactation (Baldi and Pinotti, 
2006). Indeed, more than 50% of high producing cows experience moderate to severe fatty liver 
disease at the onset of lactation (Bobe et al., 2004), which is a classic symptom of choline 
deficiency (Garrow, 2007) . Therefore, microencapsulated technology has been developed to 
protect choline from degradation in the rumen and deliver it to the small intestine. Commercially 
available rumen protected choline, containing 28–50% choline chloride, protects ca. 75% of the 
choline from rumen degradation in vitro (Deuchler et l., 1998; Elek et al., 2008; Brüsemeister 
and Suedekum, 2006). Studies of the effect of rumen protected choline (RPC) supplementation 
on the performance in dairy cows of during the transition period reduced triacylglycerol 
accumulation in the liver and increase milk yield and milk fat concentration (Pinotti et al., 2010, 
Zom et al., 2011). In addition, a study conducted in dairy cows from 25 days prepartum to 80 
days postpartum reported that cows fed with RPC showed reduced incidence of clinical ketosis, 
mastitis, and morbidity (Lima et al., 2012). This is a specific role during the transition cow; 
however, cows have requirement for choline through lactation, particularly for lipid transport and 
milk fat secretion (Pinnotti et al., 2002)   
Although RPC supplementation improvements on the performance have been well 






rumen protection can be relatively easily accomplished through incubating products in rumen 
fluid, and has been successfully applied to evaluate protection of various RPC products (Kung Jr 
et al., 2003, Elek et al., 2008) this approach will not give an indication of the bioavailability of 
choline in the animal. Deuchler et al. (1998) provides evidence that choline supplemented in 
rumen-protected form or post-ruminal supply was available for absorption and secreted as total 
choline in milk, however graded doses of choline post-ruminal infused resulted in a curvilinear 
response. Recently, a study in supplemented (750 mg choline/d) breast-feeding women, founde 
that the total intake of choline influenced the concentrations of choline metabolites in the breast 
milk and blood of lactating women (Fischer et al., 2010). Therefore, choline metabolites might 
be a better indicator of choline supply than the concentration of total choline in blood and milk. 
The objectives of the current study were twofold. Firstly, we sought to determine how 
graded levels of choline chloride post-ruminal infused were absorbed across the intestine and 
metabolized by the liver. This is important as there is not a clear understanding of absorption of 
freely available choline in the small intestine of ruminants. Secondly, we sought to evaluate 
whether a marker for choline absorption can be obtained from easily available sampling 
approaches (i.e. choline metabolites in blood and milk). If a biomarker for absorbed choline can 
be established it will more readily allow bioavailability trials to be conducted to assess delivery 
efficacy of RPC products. In an attempt to shed light on choline absorption in dairy cows we 
determined the bioavailability of RPC in the intestine, and choline metabolism across the liver at 









Materials and Methods 
Animals were cared for according to the recommended Code of Practice for the Care and 
Handling of Dairy Cattle and the guidelines of the Canadian Council on Animal Care (2009). 
Five lactating Holstein cows (206 ± 25 DIM and averaging 708 kg ± 89 kg of BW, mean ± SE, 
respectively) equipped with a rumen cannula and chronic indwelling catheters in the portal, 
hepatic and 2 mesenteric veins as well as in a mesenteric artery (Huntington et al., 1989) at least 
five months before the start of the experiment were used. The catheters were exteriorized 
individually over the paralumbar shelf and spine. The right carotid artery was surgically raised to 
a subcutaneous position to allow access to arterial blood if the catheter placed in a mesenteric 
artery failed. In instances where both arterial catheters failed, an auricular artery was used. The 
cows were randomly assigned to treatment in a 55 Latin square design, with 5-d treatment 
periods and a 2-d interval between periods. Treatments were 1) control (0 g/d choline), 2) RPC - 
low dose (RPC-L), 3) RPC - high dose (RPC-H), 4) post-ruminal infusion (ABO) – low dose 
(ABO-L), 5) ABO - high dose (ABO-H). The low and high doses of RPC (Reashure, Balchem 
Corporation, New Hampton, NY; containing 21.6% of choline) and ABO each supplied 12.5 and 
25 g choline/d, respectively. Choline (aqueous choline chloride 70%; Balchem Corporation, New 
Hampton, NY; containing 52.3% of choline) was infused post-ruminally continuously over the 5 
d, whilst the RPC treatments were fed 12x/d as a top dress. The choline chloride was dissolved in 
tap water and was infused continuously through a peristaltic pump in a daily volume of 6 L/cow 
(260 mL/h) for the duration of each experimental period. 
Cows were housed in a tie-stall barn with free access to water under 16 h of light per day 
(0500 to 2200 h) and were fed in the morning 1 kg of long hay per day and a TMR (Table 4.1) 






95% of their voluntary feed intake measured the week before the start of the study. Feed intake 
and refusals, when present, were weighed and recorded daily. Cows were milked twice a daily 
(0700 and 1900 h) and yields at each milking were recorded. At the last day of each experimental 
period milk was collected at 2 consecutive milkings (pm, am) to determine fat and protein 
content (DHI agency, Valacta, St-Anne-de Bellevue, QC, Canada). 
On the last day of each 5 d-period, blood samples (n = 9) were taken simultaneously from 
the 4 catheters every 30 min during 4 consecutive hours starting at the 0900 h meal. Immediately 
after collection, blood samples were put in Vacutainer tubes with EDTA (Becton Dickinson Inc., 
Franklin Lakes, NJ), the tubes were then placed on ice until centrifuged (2000 × g for 10 min at -
4°C). Plasma was collected and stored at –80 °C until sample analysis.  
Milk samples from the last day of each period were collected at 2 consecutive milkings (pm, am) 
and were composited proportional to milk yield at each milking prior to extraction for choline 
analysis. 
Feed ingredients were sampled weekly and frozen at -20°C for chemical composition analyses 
(Table 4.1) and choline metabolites (Table 4.2). Samples were dried, ground and analyzed for 
DM, CP, ash, ether extract, ADF, NDF, and acid detergent lignin (Ankom200 fiber analyzer, 
Ankom Technology Corp., Fairport, NY) and cobalt (Agri-Food Laboratories, Guelph, ON, 
Canada). 
Milk, plasma and feed samples were extracted (Bligh and Dyer, 1959) and analyzed for 
ACho, Bet, Cho, GPCho, LPC, PC, PCho and SM, using HILIC LC-MS/MS based on methods 
outlined by Zhao et al. (2011) as described by Artegoitia et al. (2014). The following standards 
were used: Cho chloride-trimethyl-d9 (Cho-d9, Cambridge Isotope Laboratories DLM 549-1, 






PC chloride (PCh-d9,C/D/N Isotopes ICD D-2135, QC, Canada) PtC-d62 (Cambridge Isotope 
Laboratories DLM 606-0.1, Tewksbury, MA), SM-d13-c13 (Ricerca-custom made, Painesville, 
OH) AC-d13(C/D/N Isotopes ICN D-1780, QC, Canada), LPC-D31 (Avanti polar lipids, 
860397, Alabaster, AL). 
Statistical analyses for arterial, portal and hepatic concentrations, veno-arterial 
differences were conducted on the average for the 9 sampling times. One cow did not have a 
catheter in hepatic vein throughout the experiment.  In the last experimental period one cow lost 
the portal catheter (RPC-L). Average DMI and milk production during the last 2 d of each 
experimental period as well as milk composition were analyzed. All variables were analyzed 
using mixed procedure of SAS (SAS version 9.3 Institute Inc., Cary, NC, USA) according to the 
following model: 
Yijk = μ + Ci + Pj + Sk + εijk, 
where Yijk is the studied variable, μ is the overall mean, Ci is the cow effect, Pj is the period 
effect, Sk is the choline treatment effect, and εijk is the residual error. Period and choline 
treatment effects were analyzed as fixed effects and cow as a random effect. Means are reported 
as least squares means with their respective pooled standard errors and considered to differ when 
P ≤ 0.05. 
Variable selection of choline metabolites in milk was performed using the all possible methods 
approach and relationships between selected variables were ranked by R
2
 using PROC REG. 
Finally, multiple regression analysis was conducted using PROC REG to assess the relationship 









The total amount of choline in the TMR was 92.4 mg/100g calculated from the proportion of 
individual ingredients (Table 4.1 and Table 4.2). Dry matter intake also was not different across 
treatments and the total amount of choline fed was 19.46 ± 2.22 g/d.  
Milk yield and milk composition were not affected by choline either supplemented or 
post-ruminal infused (Table 4.3, P > 0.2). 
Plasma choline metabolite concentrations on artery and differences between portal and 
artery, and differences between hepatic and artery concentrations are reported in Table 4.4. The 
arterial concentrations and differences across portal-artery and hepatic-artery for total choline 
and the lipid soluble choline metabolites, LPC, PC and SM were not affected by treatment 
(P≥0.06) The arterial concentrations of water soluble choline metabolites, Cho,  et and PCho 
were increased with ABO-L  and ABO-H (P<0.01), while arterial PCho was also increased for 
RPC-H (P<0.01). The portal-arterial difference for Cho increased almost 3 times with ABO-H 
compared to the control (P<0.01), while ABO-L and RPC treatments were not different. 
Although total choline yield in milk was not affected by treatment (Table 4.5), the yield 
of the choline moiety in milk increased by 0.59 g/d for RPC-H and 1.28 g/d for ABO-H, 
representing an increase of 15% and 33%, respectively (p<0.01; Table 4.6). Cho and Bet yield 
increased (P < 0.01) in a dose dependent manner with post-ruminal infusion by 74% and 171%, , 
with ABO-L and 146% and 278% with ABO-H, respectively. The amounts of Cho and Bet 
secreted in milk increased from 0.54 to 0.94 and 1.33 g/d and from 0.14 to 0.38 and 0.53 g/d, 
respectively for the low and high doses. An increase in the yields of ACho and PC were also 
observed (P = 0.04), although only with ABO-H. The other metabolites were not changed by 






metabolites with RPC. Multiple regression analysis found that the choline post-ruminal infusion 
could be explained to a large degree by milk PC and Bet yield (P <0.01; R
2
 = 0.76). The model 
obtained for A O dose of choline in milk (γ; g/d) was 
 
                                           
 
Where Betaine and Phosphocholine are the yield in milk (g/d); SEE 7.48 and 3.67, respectively 
Discussion 
In dairy cows, choline has been proposed as a limiting nutrient, primarily during the transition 
period (Erdman and Sharma, 1991, Pinotti et al., 2002). Higher choline availability (by feeding 
RPC) can have a favorable effect on the production performance at the onset of the lactation 
(Erdman and Sharma, 1991, Pinotti et al., 2003, Zom et al., 2011). Although evaluating rumen 
protection can be relatively easily accomplished through incubating products in rumen fluid, and 
has been successfully applied to evaluate protection of various products (Kung Jr et al., 2003, 
Elek et al., 2008), this approach will not give an indication of the bioavailability of choline in the 
animal. Indeed, low degradation rate in the rumen of RPC (~20%) does not guarantee post 
ruminal bioavailability. Therefore, characterizing the net flux of choline metabolites across the 
intestine and liver as the supply of choline is increased may form the basis to understand choline 
absorption and metabolism and improving the efficacy of the level of supplementation of RPC 
during lactation in dairy cows.  
In plasma PC was the main choline metabolite (95%), similar to previous studies in 
ruminant (Robinson et al., 1984; Artegoitia et al., 2014) and non-ruminants (da Costa et al., 






affected by choline supplementation or infusion in our study, Cho and Bet arterial concentrations 
increased in plasma as the amount of Cho infused increased as well as PCho increased with RPC. 
The increase of plasma Cho concentrations on arterial as post-ruminal Cho infusion dose 
increased. Similar to our results, in breast feeding woman, dietary choline supplementation (750 
mg/d) increased the concentrations Cho and Bet in plasma but not the concentrations of PC, SM 
while PCho was not measured (Fischer et al., 2010). Cho is transported by the portal blood to be 
metabolized mainly by the liver for biosynthesis of phospholipid or conversion to the methyl 
donor betaine (Zeisel et al., 1991). Upon entry into a cell, Cho is rapidly phosphorylated to PCho 
by choline kinase, a cytosolic enzyme that catalyzes the initial step of CDP-choline pathway. As 
intracellular concentrations of Cho increase, choline kinase becomes saturated and the majority 
of choline enters the mitochondria where it is converted to betaine. Thus, choline oxidation is 
considered as a “spillover” pathway under high choline supply (Caudill et al., 2012). Once 
formed, betaine may be used as a methyl donor for the conversion of homocysteine to 
methionine, which is the first limiting amino acid required for transmethylation reactions and 
milk protein synthesis in dairy ruminants (Lobley et al., 1996).  
The main choline metabolites in milk in our study were PC (58%) and Cho (22%) across 
all treatments, respectively. This is consistent with previous research which reported similar 
proportions in bovine milk (Holmes-McNary et al., 1996, Artegoitia et al., 2014). All the 
concentrations and yields in milk of the water soluble choline metabolites and total choline in 
our results increased as choline dose infusion increased. In addition, the yield of total choline 
moiety increased 0.59 g/d with RPC-H and 1.28 g/d with ABO-H. Based on the increase in the 
choline moiety in with RPC-H and ABO-H versus the choline amount supplemented, the 






in total choline moiety in milk, Cho and Pcho represented 40% and 5%, respectively, for RPC-H 
and 60% and 24%, respectively for ABO-H. Deuchler et al. (1998) measured total choline in 
cows’ milk in mid-lactation; they found that in animals receiving post-ruminal choline infusion 
with 0, 19, 37, 56 g/d, the choline content of milk was linearly increased and the estimated 
transfer was 5.37%, 3.13% and 2.25% for post-ruminal infusion, respectively; however the 
supplementation of RPC did not change the total choline yield in milk. In addition, Pinotti et al. 
(2003) reported an increase of total choline in milk when cows were supplemented with 15 g/d of 
choline in RPC during -14d to 30 d relative to calving (control 2.53 g/d vs 3.81 g/d RPC), 
representing 8.5% transfer into milk. The basis for these differences in transfer of choline into 
milk is not clear, however, may related to choline dose, lactation stage, length of 
supplementation and effectiveness of delivery. A multiple regression analysis indicated that 
concentrations of Bet and Pcho in milk were moderate associated with the total amount of 
choline post-ruminal infused. The association found in this study, although developed based on a 
small sample set of cows at the end of the lactation, suggests that the prediction of choline supply 
may be possible based on Bet and Pcho yields in milk.  
In conclusion, the present study measured the changes of choline metabolites across intestine and 
metabolized by the liver with graded levels of choline chloride post-ruminal infused or RPC 
supplemented. The concentrations of total choline or lipid soluble choline metabolites, LPC, PC 
and SM were not affected by treatment at arterial, or across portal or hepatic veins. The 
concentrations of water soluble choline metabolites, Cho and Bet arterial concentrations were 
increased with ABO-L and ABO-H while PCho arterial concentrations increased with both 
ABO-L and ABO-H as well as and RPC-H  dose treatment. The portal-arterial difference for Cho 






treatments were not changed. Although lipid soluble metabolites or total choline in plasma was 
not affected by treatment, a low amount of total choline was transferred into milk with RPC-H 
(2.36%) and with ABO-H (5.12%). Moreover, multiple regression analysis may suggest that 
concentrations of Bet and Pcho (R
2
=0.72, P<0.01) in milk are more sensitive biomarkers for 
predicting absorption of choline. 
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Table 4.1 Ingredients and chemical composition of the total mixed ration
1
 
Ingredient, % DM basis  Value 








Canola meal 21.9 
Beet pulp 2.0 
Mineral and vitamin supplement
4 
1.8 








  DM, % 50.0 
  CP, % of DM 15.1 
  RDP, % of CP 49.4 
  Soluble protein, % of CP 31.1 
  ADF, % of DM 18.9 
  NDF, % of DM 32.6 
  NEL, Mcal/d 1.59 
  Total choline mg/100g 92.4 
1
All cows were served daily 1 kg of long hay (85% DM) on a DM 
basis, 10.5% CP; 2.5% soluble protein; 30.6% ADF; 54.4% NDF 
2
8.6% CP; 3.4% soluble protein; 21.7% ADF; 40.0% NDF 
3
16.7% CP; 7.7% soluble protein; 31.2% ADF; 47.6% NDF 
4 










































































37.4 55.7 16.8 
LPC 8.8 42.5 2.7 0.5 10.6 0.5 0.4 2.6 











0.1 0.2 0.6 
SM 0.04 0.02 0.01 0.02 1.6 0.01 0.03 0.1 













38.9 57.1 49.5 
1 
Acetylcholine (Acho) Betaine (Bet), free choline (Cho), phosphocholine (PC), 
glycerophosphocholine (GPCho),  lysophosphatidylcholine (LPC), sphingomyelin (SM), 
phosphatidylcholine (PC) 
2
































 Treatments*  
 CONTROL RPC-L RPC-H ABO-L ABO-H SEM P 
DMI, kg/d
1
 20.6 21.8 20.9 20.8 21.2    1.2 0.50 
Milk, kg/d 32.3 33.3 31.3 32.7 33.7 1.16 0.46 
Milk protein        
% 3.46 3.47 3.42 3.42 3.39 0.09 0.20 
g/d  1118 1150 1070 1122 1140 46 0.49 
Milk fat        
% 4.04 4.03 4.05 3.99 3.96 0.10 0.58 
g/d 1306 1338 1268 1326 1334 53 0.68 
* Treatments: RPC-L= rumen protected choline supplemented at 12.5g/d choline;  RPC-
H= rumen protected choline supplemented at 25g/d choline; ABO-L=abomasal infused at 












Table 4.4 Plasma choline metabolites (μmol/l) when cows were abomasal infused 
unprotected choline or supplemented rumen protected choline at different levels
1 
 
 Treatments*   
 CONTROL RPC-L RPC-H ABO-L ABO-H SEM P 



























-0.95 -0.91 -0.50 1.05 -0.81 0.70 0.31 




















-0.72 -1.38 1.86 0.95 
Hepatic-Artery
4 
0.27 0.14 -0.67 8.97 4.31 3.57 0.33 
LPC 
Artery 170.4 209.0 217.6 203.5 182.0 15.15 0.11 
Portal-Artery -7.76 -24.5 -8.35 4.78 -13.31 12.17 0.59 




























0.17 -0.07 0.19 -0.30 0.14 0.25 0.61 
PC 
Artery 7831 9139 9775 8507 7280 668 0.06 
Portal-Artery
3 
889.0 -1867 -161.4 -678.5 -547.4 1005 0.48 
Hepatic-Artery
4 
1766 -521 -757 -1055 904 1123 0.29 
SM 
Artery 247.6 241.9 288.5 250.5 266.4 15.6 0.28 
Portal-Artery
3 
1.94 -12.22 -19.55 -3.81 -17.26 12.53 0.74 
Hepatic-Artery
4 
25.1 20.89 1.39 -4.81 -14.49 13.89 0.30 
TC
2 
Artery 8228 9606 10291 8959 7747 677 0.06 
Portal-Artery
3 
896.8 -1906 -187.9 -680.2 -573.8 1013 0.47 
Hepatic-Artery
4 
1823 -517 -738 -1058 890 1137 0.40 
 
* Treatments: RPC-L= rumen protected choline supplemented at 12.5g/d choline;  RPC-H= rumen 
protected choline supplemented at 25g/d choline; ABO-L=abomasal infused at 12.5g/d choline; 
ABO-H=abomasal infused at 25g/d choline; 
1  Data are presented as LSM ± SEM. of Betaine (Bet), free choline (Cho), phosphocholine (PCho),    
lysophosphatidylcholine (LPC), sphingomyelin (SM), phosphatidylcholine (PC) 
2
 Total choline (TC) is the sum of Cho, LPC, PtC, PC  and SM  
3
Portal-Artery in plasma is calculated as the differences between the concentration of the choline 
metabolites in portal and artery 
4
 Hepatic-Artery  in plasma is calculated as the differences between the concentration of the choline 







Table 4.5 Milk choline metabolite yields (g/d) when cows were abomasal infused 

































































SM 0.93 0.87 0.99 0.83 0.89 0.08 0.21 




























*Treatments: RPC-L= rumen protected choline supplemented at 12.5g/d choline;  RPC-H= 
rumen protected choline supplemented at 25g/d choline; ABO-L=abomasal infused at 
12.5g/d choline; ABO-H=abomasal infused at 25g/d choline; 
1 
Data are presented as LSM ± SEM. of
 
Acetylcholine (Acho) Betaine (Bet), free choline 
(Cho), phosphocholine (PCho),  glycerophosphocholine (GPC),  lysophosphatidylcholine 
(LPC), sphingomyelin (SM), phosphatidylcholine (PC) 
2
 Total choline (TC) is the sum of Cho, LPC, PCho, PC, SM and GPCho. 
3 


















Table 4.6 Milk choline metabolite concentrations (μmol/l) when cows were abomasal 
































































LPC 6.36 5.96 7.29 6.56 7.12 0.77 0.72 












SM 40.95 39.64 42.00 36.98 38.98 2.97 0.30 















* Treatments: RPC-L= rumen protected choline supplemented at 12.5g/d choline;  RPC-H= 
rumen protected choline supplemented at 25g/d choline; ABO-L=abomasal infused at 
12.5g/d choline; ABO-H=abomasal infused at 25g/d choline; 
1  Data are presented as LSM ± SEM. of Acetylcholine (Acho) Betaine (Bet), free choline 
(Cho), phosphocholine (PCho),  glycerophosphocholine (GPC),  lysophosphatidylcholine 
(LPC), sphingomyelin (SM), phosphatidylcholine (PC) 
2













Improving the absorption and utilization of vitamin B12 and choline with different delivery 
methods, ultimately can enhance the productive performance in the lactating dairy cows. 
The overall goal of this research was to gain information on choline absorption and 
improve the efficacy of the level of choline and vitamin B12 supplementation during lactation in 
dairy cow. In the present research, I studied the absorption and utilization of different delivery 
systems for choline and vitamin B12 for the lactating dairy cow as well as the physiological 
variation of choline metabolites during lactation. In vivo measurements with multi-catheterized 
cows provided the net fluxes of choline and vitamin B12 across the small intestine and liver. 
Therefore, this information allowed determining absorption of choline and vitamin B12 in the 
intestine with different delivery systems as well as the metabolism across the liver at different 
level of choline supplementation. 
The dietary supplementation of vitamin B12 is costly whereas systematic use of 
intramuscular injections of the vitamin is not practical under commercial conditions. Casein and 
whey proteins as delivery methods for cyanocobalamin (CN-CBL) in solution to increase 
intestinal absorption of vitamin B12 were studied (Chapter 2). Only 0.74% of the total amount of 
vitamin B12 infused post-ruminally reached the portal blood within the first 45 min and there was 
no further release during the rest of the sampling period (24 h) after the bolus. The dose of 100 
mg of CN-CBL infused post-ruminally might not be sufficient to reach similar net release of 
vitamin B12 across intestine The intestinal absorption of CN-CBL was greater when the vitamin 
was given in solution with casein (4 μg/h) compared with CN-CBL given alone or with whey 
protein (-25 μg/h and -19 μg/h, respectively). The present results suggest that CN-CBL given 
with casein increased vitamin B12 absorption as compared to CN-CBL given alone. Therefore, 






Milk and dairy products are an important source of choline, an essential nutrient for 
human health. In addition, choline is found in various water- and lipid-soluble forms in milk, 
which are different in their absorption, transport and metabolism. Currently, there is scarce 
information about the factors that influence the concentrations of choline metabolites in milk. 
Therefore, choline and its metabolites in blood and milk through the first 37 weeks of lactation in 
the dairy cow were characterized (Chapter 3). The total choline in plasma increased over 10-fold 
from early to late lactation, with the majority of the increase coming from elevated PC levels 
which might be associated with the changes in types and levels of lipoproteins in plasma that 
occur during lactation. The concentration of the choline moiety in milk decreased from early (8 
mg/100 g) to mid-lactation (5 mg/100 g) before rising again in late lactation (11 mg/100g); 
however, throughout lactation milk choline remained below the levels reported previously in 
commercial milk (16 mg/100 g). This large difference in choline levels in milk needs further 
evaluation to ensure that choline intake meets requirements to the human population. In milk 
phosphocholine was the main metabolite in early lactation and decreased rapidly over the first 
weeks of lactation. In contrast, phosphatidylcholine in milk was lowest in early lactation and 
increased steadily through lactation, with this change positively correlated with 
phosphatidylcholine in plasma. Also, we found that production variables (milk yield and milk fat 
and protein content) along with week of lactation were correlated with total milk choline yield, 
suggesting that it may be possible to predict milk choline output from easily measureable 
variables on the farm. 
In dairy cows, supplementation of rumen protected choline (RPC) can improve the 
performance during the transition period. Although evaluating rumen protection can be relatively 






indication of the bioavailability of choline in the animal. Therefore, choline and its metabolites 
were measured across the intestine and liver and ultimate in the milk, when low (L) and high (H) 
graded levels of choline were post-ruminal infused (ABO) or supplemented with RPC (Chapter 
4). Notwithstanding plasma arterial total choline and lipid soluble choline metabolite 
concentrations were not affected by treatment, choline, betaine and phosphocholine 
concentrations increased with choline post-ruminal infusion as well as phosphocholine with 
RPC. The total choline moiety increased 0.59 g/d with RPC-H and 1.28 g/d with ABO-H. Based 
on the increase in milk total choline with RPC-H and ABO-H, the transfer of choline into milk 
was approximately 2.36 % and 5.12 %, respectively. For the increase in total choline moiety in 
milk, choline and phosphocholine represented 40% and 5%, respectively, for RPC-H and 60% 
and 24%, respectively, for ABO-H. The low amount of choline transfer into milk are not well 
understand and might be related to choline dose, lactation stage, length of supplementation and 
effectiveness of delivery. A multiple regression analysis indicated that concentrations of betaine 
and phosphocholine in milk were moderate associated with the total amount of choline post-
ruminal infused. The correlation found in this study, although developed based on a small sample 
set of cows at the end of the lactation, suggest that the prediction of the level of choline 
supplementation may be possible based on betaine and phosphocholine yields in milk.  
This information can be utilized by the feed industry to develop improved formulation to 
increase absorption of choline and vitamin B12, which ultimately can be used to nutritionist for 
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